COVER PAGE
COVER PAGE - shares | 3 Months Ended | |
Mar. 31, 2023 | May 10, 2023 | |
Entity Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-39755 | |
Entity Registrant Name | Navitas Semiconductor Corporation | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 85-2560226 | |
Entity Address, Address Line One | 3520 Challenger Street | |
Entity Address, Postal Zip Code | 90503-1640 | |
Entity Address, City or Town | Torrance, | |
Entity Address, State or Province | CA | |
City Area Code | 844 | |
Local Phone Number | 654-2642 | |
Title of 12(b) Security | Class A Common Stock,par value $0.0001 per share | |
Trading Symbol | NVTS | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Amendment Flag | false | |
Entity Central Index Key | 0001821769 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q1 | |
Current Fiscal Year End Date | --12-31 | |
Common Class A | ||
Entity Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 160,932,436 | |
Common Class B | ||
Entity Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 0 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 100,823 | $ 110,337 |
Accounts receivable, net (less allowance of $300 and $0) | 7,423 | 9,127 |
Inventories | 18,873 | 19,061 |
Prepaid expenses and other current assets | 2,880 | 3,623 |
Total current assets | 129,999 | 142,148 |
PROPERTY AND EQUIPMENT, net | 6,840 | 6,532 |
OPERATING LEASE RIGHT OF USE ASSETS | 6,537 | 6,381 |
INTANGIBLE ASSETS, net | 105,569 | 105,620 |
GOODWILL | 161,442 | 161,527 |
OTHER ASSETS | 5,581 | 3,054 |
Total assets | 415,968 | 425,262 |
CURRENT LIABILITIES: | ||
Accounts payable and other accrued expenses | 13,610 | 14,653 |
Accrued compensation expenses | 7,711 | 3,907 |
Operating lease liabilities, current | 1,477 | 1,305 |
Other liabilities | 674 | 486 |
Total current liabilities | 23,472 | 20,351 |
Operating lease liabilities - noncurrent | 5,248 | 5,263 |
EARNOUT LIABILITY | 40,816 | 13,064 |
DEFERRED TAX LIABILITIES | 1,829 | 1,824 |
Total liabilities | 71,365 | 40,502 |
COMMITMENTS AND CONTINGENCIES (Note 15) | ||
STOCKHOLDERS’ EQUITY: | ||
Common stock, $0.0001 par value, 750,000,000 shares authorized as of both March 31, 2023 and December 31, 2022, and 160,943,107 and 153,628,838 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively | 18 | 18 |
Additional paid-in capital | 561,193 | 535,875 |
Accumulated other comprehensive loss | (7) | (7) |
Accumulated deficit | (216,601) | (154,754) |
Total stockholders’ equity of Navitas Semiconductor Corporation | 344,603 | 381,132 |
Noncontrolling interest | 0 | 3,628 |
Total stockholders’ equity | 344,603 | 384,760 |
Total liabilities and stockholders’ equity | $ 415,968 | $ 425,262 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance | $ 300 | $ 0 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 750,000,000 | 750,000,000 |
Common stock shares issued (in shares) | 160,943,107 | 153,628,838 |
Common stock, shares outstanding (in shares) | 160,943,107 | 153,628,838 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
NET REVENUES (including $0 and $613 of related party revenues) | $ 13,358 | $ 6,740 |
COST OF REVENUES (exclusive of amortization of intangible assets included below) | 7,873 | 3,777 |
OPERATING EXPENSES: | ||
Research and development | 17,394 | 13,325 |
Selling, general and administrative | 19,058 | 24,544 |
Amortization of intangible assets | 4,499 | 88 |
Total operating expenses | 40,951 | 37,957 |
LOSS FROM OPERATIONS | (35,466) | (34,994) |
OTHER INCOME (EXPENSE), net: | ||
Interest income (expense), net | 903 | (24) |
Gain from change in fair value of warrants | 0 | 51,763 |
Gain (loss) from change in fair value of earnout liabilities | (27,752) | 63,406 |
Other income (expense) | 11 | (356) |
Total other income (expense), net | (26,838) | 114,789 |
INCOME (LOSS) BEFORE INCOME TAXES | (62,304) | 79,795 |
INCOME TAX PROVISION | 61 | 3 |
NET INCOME (LOSS) | (62,365) | 79,792 |
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS | (518) | 0 |
NET INCOME (LOSS) ATTRIBUTABLE TO CONTROLLING INTERESTS | $ (61,847) | $ 79,792 |
NET INCOME (LOSS) PER COMMON SHARE: | ||
Basic net income (loss) per share attributable to common stockholders (in dollars per share) | $ (0.39) | $ 0.67 |
Diluted net income (loss) per share attributable to common stockholders (in dollars per share) | $ (0.39) | $ 0.61 |
WEIGHTED AVERAGE COMMON SHARES USED IN NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS: | ||
Basic common shares (in shares) | 156,792 | 119,542 |
Diluted common shares (in shares) | 156,792 | 131,149 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
NET REVENUES (including $0 and $613 of related party revenues) | $ 13,358 | $ 6,740 |
Affiliated Entity | ||
NET REVENUES (including $0 and $613 of related party revenues) | $ 0 | $ 613 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
NET INCOME (LOSS) | $ (62,365) | $ 79,792 |
Other comprehensive income (loss), net of tax: | ||
Foreign currency translation adjustments, net of tax | 0 | (60) |
Total other comprehensive income (loss) | 0 | (60) |
COMPREHENSIVE INCOME (LOSS) INCLUDING NONCONTROLLING INTEREST | (62,365) | 79,732 |
COMPREHENSIVE INCOME ATTRIBUTABLE TO NONCONTROLLING INTEREST | (518) | 0 |
TOTAL COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CONTROLLING INTEREST | $ (61,847) | $ 79,732 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands | Total | Common stock | Additional paid in capital | Accumulated deficit | Accumulated comprehensive income (loss) | Noncontrolling interest |
Beginning balance, common stock (in shares) at Dec. 31, 2021 | 117,751,000 | |||||
Beginning balance, common stock at Dec. 31, 2021 | $ 65,536 | $ 15 | $ 294,190 | $ (228,667) | $ (2) | $ 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Issuance of common stock under employee stock option and stock awards plans (in shares) | 2,459,000 | |||||
Issuance of common stock under employee stock option and stock award plans | 1,305 | 1,305 | ||||
Repurchase of common stock (in shares) | (67,000) | |||||
Repurchase of common stock | (550) | (550) | ||||
Exercise of warrants (in shares) | 3,318,000 | |||||
Exercise of warrants | 29,641 | 29,641 | ||||
Stock-based compensation expense related to employee and non-employee stock awards | 24,072 | 24,072 | ||||
Foreign currency translation adjustment | (60) | (60) | ||||
Net income (loss) | 79,792 | 79,792 | ||||
Ending balance, common stock (in shares) at Mar. 31, 2022 | 123,461,000 | |||||
Ending balance, common stock at Mar. 31, 2022 | $ 199,736 | $ 15 | 348,658 | (148,875) | (62) | 0 |
Beginning balance, common stock (in shares) at Dec. 31, 2022 | 153,628,838 | 153,629,000 | ||||
Beginning balance, common stock at Dec. 31, 2022 | $ 384,760 | $ 18 | 535,875 | (154,754) | (7) | 3,628 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Issuance of common stock under employee stock option and stock awards plans (in shares) | 3,082,000 | |||||
Issuance of common stock under employee stock option and stock award plans | 2,925 | 2,925 | ||||
Shares issued in connection with buyout agreement (in shares) | 4,232,000 | |||||
Shares issued in connection with buyout agreement | 4,399 | 7,509 | (3,110) | |||
Stock-based compensation expense related to employee and non-employee stock awards | 14,884 | 14,884 | ||||
Foreign currency translation adjustment | 0 | |||||
Net income (loss) | $ (62,365) | (61,847) | (518) | |||
Ending balance, common stock (in shares) at Mar. 31, 2023 | 160,943,107 | 160,943,000 | ||||
Ending balance, common stock at Mar. 31, 2023 | $ 344,603 | $ 18 | $ 561,193 | $ (216,601) | $ (7) | $ 0 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net income (loss) | $ (62,365) | $ 79,792 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
Depreciation | 506 | 125 |
Amortization expense | 4,536 | 88 |
Non-cash lease expense | 512 | 243 |
Other | 85 | (357) |
Stock-based compensation expense | 17,161 | 25,326 |
Amortization of debt discount and issuance costs | 0 | 3 |
Gain from change in fair value of warrants | 0 | (51,763) |
(Gain) loss from change in fair value of earnout liability | 27,752 | (63,406) |
Deferred income taxes | 5 | 0 |
Change in operating assets and liabilities: | ||
Accounts receivable | 1,704 | (1,358) |
Inventory | 188 | (1,152) |
Prepaid expenses and other current assets | 743 | (109) |
Other assets | (1,612) | 1,391 |
Accounts payable, accrued compensation and other expenses | 3,376 | 817 |
Operating lease liability | (511) | (241) |
Net cash used in operating activities | (7,920) | (10,601) |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Investment purchases | (1,000) | 0 |
Investment in Joint Venture | 0 | (2,704) |
Purchases of property and equipment | (815) | (294) |
Receipts on notes receivable | 0 | 6 |
Net cash used in investing activities | (1,815) | (2,992) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Redemption of warrants | 0 | (38) |
Repurchase of common stock | 0 | (550) |
Proceeds from issuance of common stock in connection stock option exercises | 221 | 526 |
Principal payments on long-term debt | 0 | (800) |
Net cash provided by (used in) financing activities | 221 | (862) |
NET DECREASE IN CASH AND CASH EQUIVALENTS | (9,514) | (14,455) |
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 110,337 | 268,252 |
CASH AND CASH EQUIVALENTS AT END OF PERIOD | 100,823 | 253,797 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||
Cash paid for income taxes | 10 | 23 |
Cash paid for interest | 0 | 67 |
Shares issued in connection with buyout agreement (see Note 18) | 22,400 | 0 |
Capital expenditures in accounts payable | $ 228 | $ 0 |
ORGANIZATION AND BASIS OF PRESE
ORGANIZATION AND BASIS OF PRESENTATION | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND BASIS OF PRESENTATION | ORGANIZATION AND BASIS OF PRESENTATION On May 6, 2021, Navitas Semiconductor Limited, a private company limited by shares organized under the laws of Ireland (“Navitas Ireland”) and domesticated in the State of Delaware as Navitas Semiconductor Ireland, LLC, a Delaware limited liability company (“Navitas Delaware” and, together with Navitas Ireland, “Legacy Navitas”), entered into a business combination agreement and plan of reorganization (the “Business Combination Agreement” or “BCA”) with Live Oak Acquisition Corp. II, a Delaware corporation (“Live Oak”). Pursuant to the BCA, among other transactions consummated on October 19, 2021 (collectively, the “Business Combination”), Live Oak acquired all of the capital stock of Navitas Ireland (other than the Navitas Ireland Restricted Shares, as defined below) by means of a tender offer, and a wholly owned subsidiary of Live Oak merged with and into Navitas Delaware, with Navitas Delaware surviving the merger. As a result, Legacy Navitas became a wholly owned subsidiary of Live Oak effective October 19, 2021. At the closing of the Business Combination, Live Oak changed its name to Navitas Semiconductor Corporation (“Navitas”). References to the “Company” in these financial statements refer to Legacy Navitas and its predecessors before the consummation of the Business Combination, or to Navitas Semiconductor Corporation after the Business Combination, as the context suggests. The Company designs, develops and markets next-generation power semiconductors including gallium nitride (“GaN”) power integrated circuits (“ICs”), silicon carbide (“SiC”) and associated high-speed silicon system controllers, and digital isolators used in power conversion and charging. Power supplies incorporating the Company’s products may be used in a wide variety of electronics products including fast chargers for mobile phones and laptops, consumer electronics, data centers, solar inverters and electric vehicles, among numerous other applications. The Company’s products provide superior efficiency, performance, size, cost and sustainability relative to existing silicon technology. The Company presently operates as a product design house that contracts the manufacturing of its chips and packaging to partner suppliers. Navitas maintains its operations around the world, including the United States, Ireland, Germany, Italy, Belgium, China, Taiwan, Thailand and the Philippines, with principal executive offices in Torrance, California. Reorganization Navitas Semiconductor USA, Inc. (f/k/a Navitas Semiconductor, Inc., “Navitas U.S.”) was incorporated in the State of Delaware on October 25, 2013. In 2020 Navitas U.S. initiated a restructuring to streamline its worldwide legal entity structure and more efficiently align its business operations (the “Restructuring”). The Restructuring introduced wholly owned subsidiaries in Hong Kong and China as well as the addition of Legacy Navitas, an entity registered in Ireland and the U.S., as the parent of Navitas U.S. and the other Navitas subsidiaries. In connection with the Restructuring, effective September 1, 2020, Legacy Navitas acquired certain intellectual property and other intangible assets from Navitas U.S. and, after the Restructuring, contracts directly with customers. The transfer of intellectual property and other intangible assets by Navitas U.S. to Legacy Navitas in connection with the Restructuring was among entities within the same consolidated group and, as a result, did not result in any gain or loss to the Company. Legacy Navitas is treated as a corporation for U.S. federal income tax purposes and is a tax resident in both Ireland and the United States. See Note 14, Provision for Income Taxes, for more information. Acquisitions In June 2022, the Company acquired VDDTECH srl, a Belgian private company, for approximately $1.9 million in cash and stock , and in August 2022 the Company acquired GeneSiC for approximately $246.2 million in cash and stock. S ee Note 17, Business Combinations, for more information. In January 2023, the Company announced an agreement to acquire the remaining minority interest in its silicon control IC joint venture from Halo Microelectronics International Corporation for a purchase price of $22.4 million in Navitas stock. The transaction was completed in February 2023. See Note 18, Noncontrolling Interest, for more information Basis of Consolidation The accompanying condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The results of operations for the three months ended March 31, 2023 shown in this report are not necessarily indicative of results to be expected for the full year ending December 31, 2023. In the opinion of the Company’s management, the information contained herein reflects all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the Company’s results of operations, financial position, cash flows and stockholders’ equity (deficit). Certain footnote disclosures normally included in annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (“SEC”) rules and regulations relating to interim financial statements. The accompanying condensed consolidated financial statements should be read in conjunction with consolidated financial statements and notes thereto contained in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on April 3, 2023. Except as further described below, there have been no significant changes in the Company’s accounting policies from those disclosed in its Form 10-K filed with the SEC on April 3, 2023. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material intercompany transactions between and among the Company and its consolidated subsidiaries have been eliminated in consolidation. The Company’s net income (loss) excluded income (loss) attributable to the noncontrolling interests. The consolidated financial statements include the accounts of Elevation Semiconductor Inc. (the “Joint Venture”), an entity in which the Company had a controlling interest since August 19, 2022 (see Note 18, Noncontrolling Interest). During the first quarter of fiscal year 2023 the Company acquired the remaining noncontrolling interest in the Joint Venture. The transaction was completed on February 13, 2023. As Navitas already had a controlling interest, financial results from the Joint Venture have already been reflected in Navitas’ historical financial statements. The condensed consolidated financial statements include the accounts of the Company, its wholly owned or majority-owned subsidiaries and entities in which the Company is deemed to have a direct or indirect controlling financial interest based on either a variable interest model or voting interest model. All intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. On an ongoing basis, management evaluates the assumptions used in making estimates, including those related to (i) the collectability of accounts receivable; (ii) write-down for excess and obsolete inventory; (iii) warranty obligations; (iv) the value assigned to and estimated useful lives of long-lived assets; (v) the realization of tax assets and estimates of tax liabilities and tax reserves; (vi) recoverability of intangible assets; (vii) the computation of share-based compensation; (viii) accrued compensation and other expenses; and (ix) the recognition of revenue. These estimates are based on historical data and experience, as well as various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company engages third-party valuation specialists to assist with estimates related to the valuation of intangible assets, stock options, restricted common stock awards,earnout shares and warrants. Such estimates often require the selection of appropriate valuation methodologies and models, and significant judgment in evaluating ranges of assumptions and financial inputs. Actual results could differ from those estimates. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS | SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS Business Combinations We account for business combinations using the acquisition method of accounting, in accordance with Accounting Standards Codification (“ASC”) 805 , “ Business Combinations” . The acquisition method requires identifiable assets acquired and liabilities assumed to be recognized and measured at fair value on the acquisition date, which is the date that the acquirer obtains control of the acquired business. The amount by which the fair value of consideration transferred exceeds the net fair value of assets acquired and liabilities assumed is recorded as goodwill. The determination of estimated fair value requires us to make significant estimates and assumptions. These fair value determinations require judgment and involve the use of significant estimates and assumptions, including assumptions with respect to future cash inflows and outflows, discount rates, and asset lives, among other items. As a result, we may record adjustments to the fair values of assets acquired and liabilities assumed within the measurement period (up to one year from the acquisition date) with the corresponding offset to goodwill. Transaction costs associated with business combinations are expensed as they are incurred. Valuation of Contingent Consideration Resulting from a Business Combination In connection with certain acquisitions, we may be required to pay future consideration that is contingent upon the achievement of specified milestone events. We record contingent consideration resulting from a business combination at its fair value on the acquisition date. Each quarter thereafter, we revalue these obligations and record increases or decreases in their fair value within our Condensed Consolidated Statements of Operations until such time as the specified milestone achievement period is complete. Increases or decreases in fair value of the contingent consideration liabilities can result from updates to assumptions such as the expected timing or probability of achieving the specified milestones. Significant judgment is employed in determining these assumptions as of the acquisition date and for each subsequent period. Updates to assumptions could have a significant impact on our results of operations in any given period. Actual results may differ from estimates. Recently Adopted Accounting Standards Credit Losses In June 2016, the Financial Accounting Standards Board (“FASB”) amended guidance related to impairment of financial instruments as part of ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which replaced the incurred loss impairment methodology with an expected credit loss model for which a company recognizes an allowance based on the estimate of expected credit loss. This ASU requires entities to measure the impairment of certain financial instruments, including accounts receivable, based on expected losses rather than incurred losses. For companies that qualify under the emerging growth company exemptions, this ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted, and is effective for the Company beginning in 2023. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures. We pool financial assets based on their risk characteristics, which include class of customer, geographic location of the customer, contractual life of the financial asset, and age of the open receivable balance. The allowance for credit losses pool is estimated based on historical credit loss rates adjusted for management’s reasonable and supportable expectations of future economic conditions, which consider macroeconomic, industry and market trends that could impact future credit loss rates. Additions to the allowance are charged to general and administrative expenses in the consolidated statements of operations. Accounts receivable are written off against the allowance when the probability of collection of an account balance is deemed remote. |
INVENTORY
INVENTORY | 3 Months Ended |
Mar. 31, 2023 | |
Inventory Disclosure [Abstract] | |
INVENTORY | INVENTORY Inventory consists of the following (in thousands): March 31, 2023 December 31, 2022 Raw materials $ 3,551 $ 4,314 Work-in-process 11,609 9,166 Finished goods 3,713 5,581 Total $ 18,873 $ 19,061 |
PROPERTY AND EQUIPMENT, NET
PROPERTY AND EQUIPMENT, NET | 3 Months Ended |
Mar. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY AND EQUIPMENT, NET | PROPERTY AND EQUIPMENT, NET Property and equipment, net consist of the following (in thousands): March 31, 2023 December 31, 2022 Furniture and fixtures $ 202 $ 215 Computers and other equipment 8,064 7,251 Leasehold improvements 2,045 2,054 Construction in Progress 71 — 10,382 9,520 Accumulated depreciation (3,542) (2,988) Total $ 6,840 $ 6,532 For the three months ended March 31, 2023 and 2022, depreciation expense w as $0.5 million and $0.1 million, respectively, and was determined using the straight-line method over the following estimated useful lives: Furniture and fixtures 3 — 7 years Computers and other equipment 2 — 5 years Leasehold improvements 2 — 5 years |
FAIR VALUE OF FINANCIAL ASSETS
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES | FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES The accounting guidance on fair value measurements clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices for identical assets in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. The short-term nature of the Company’s cash and cash equivalents, accounts receivable, debt and current liabilities causes each of their carrying values to approximate fair value for all periods presented. Cash equivalents classified as Level 1 instruments were not material as of March 31, 2023 and December 31, 2022. The following table presents the Company’s fair value hierarchy for financial liabilities as of March 31, 2023 (in thousands) : Level 1 Level 2 Level 3 Total Liabilities: Earnout liability $ — $ — $ 40,816 $ 40,816 Total $ — $ — $ 40,816 $ 40,816 The following table presents the Company’s fair value hierarchy for financial liabilities as of December 31, 2022 (in thousands): Level 1 Level 2 Level 3 Total Liabilities: Earnout liability $ — $ — $ 13,064 $ 13,064 Total $ — $ — $ 13,064 $ 13,064 The following table provides a reconciliation between the beginning and ending balances of items measured at fair value on a recurring basis that used significant unobservable inputs (Level 3) (in thousands): Fair Value Measurements Using Significant Unobservable Inputs Balance at December 31, 2022 $ 13,064 Fair value adjustment 27,752 Balance at March 31, 2023 $ 40,816 The Company did not transfer any investments between Level 1 and Level 2 of the fair value hierarchy during the three months ended March 31, 2023. |
GOODWILL AND INTANGIBLES
GOODWILL AND INTANGIBLES | 3 Months Ended |
Mar. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
GOODWILL AND INTANGIBLES | GOODWILL AND INTANGIBLES Goodwill represents the excess of the consideration transferred over the estimated fair value of assets acquired and liabilities assumed in a business combination. Intangible assets are measured at their respective fair values as of the acquisition date and may be subject to adjustment within the measurement period, which may be up to one year from the acquisition date. Goodwill and indefinite-lived intangible assets are tested for impairment annually, or more frequently if events or changes in circumstances indicate that it is more likely than not that the assets are impaired. The following table presents the changes in the Company’s goodwill balance (in thousands): Goodwill Balance at December 31, 2022 $ 161,527 Purchase price adjustment (85) Balance at March 31, 2023 $ 161,442 Refer to Note 17, Business Combinations, for further details. . The following table presents the Company’s intangible asset balance by asset class as of March 31, 2023 (in thousands): Intangible Asset Cost Accumulated Amortization Net Book Value Amortization Method Useful Life Trade Names $ 900 $ (281) $ 619 Straight line 2 years Developed Technology 53,500 (7,672) 45,828 Straight line 4-10 years In-process R&D 1,177 — 1,177 Indefinite N/A Patents 33,900 (1,412) 32,488 Straight line 5-15 years Customer Relationships 24,300 (1,519) 22,781 Straight line 10 years Non-Competition Agreements 1,900 (238) 1,662 Straight line 5 years Other 1,926 (912) 1,014 Straight line 5 years Total $ 117,603 $ (12,034) $ 105,569 The following table presents the changes in the Company’s intangible asset balance (in thousands): Intangible Assets, net Balance at December 31, 2022 $ 105,620 Additions to intangible assets 4,485 Amortization expense (4,536) Balance at March 31, 2023 $ 105,569 The amortization expen se was $4.5 million and $0.1 million for the three months ended March 31, 2023 and 2022, respectively. There were no impairment charges during the three months ended March 31, 2023 and 2022. |
DEBT OBLIGATIONS
DEBT OBLIGATIONS | 3 Months Ended |
Mar. 31, 2023 | |
Debt Disclosure [Abstract] | |
DEBT OBLIGATIONS | DEBT OBLIGATIONSOn April 29, 2020, the Company entered into a loan and security agreement with a new bank (the “Term Loan”), which provided for term advances up to $8.0 million. As of March 31, 2023, this loan had been paid in full.In connection with execution of the Term Loan, the Company issued warrants to the bank (see Note 10. Warrant Liability). The fair value of the warrants at the date of issuance was not material and was recorded as debt discount, subject to amortization using the effective interest rate method over the term of the loan. All warrants were redeemed by December 31, 2022, and amortization of debt discount and issuance costs was not significant either of the three months ended March 31, 2023 or 2022. |
LEASES
LEASES | 3 Months Ended |
Mar. 31, 2023 | |
Leases [Abstract] | |
LEASES | LEASES: The Compa ny has entered into operating leases primarily for commercial buildings. These leases have terms which range from 0.5 to 5.7 years. As of March 31, 2023 no operating lease agreements contain economic penalties for the Company to extend the lease, and it is not reasonably certain the Company will exercise these extension options. Additionally, these operating lease agreements do not contain material residual value guarantees or material restrictive covenants. As of March 31, 2023 all leases recorded on the Company’s consolidated balance sheets were operating leases. Upon adoption of ASC 842 on January 1, 2022, the Company recorded operating lease assets of $1.6 million and lease liabilities of $1.7 million in the Company’s consolidated balance sheets. The adoption of this standard did not have a material impact on retained earnings, the co nsolidated statements of operations, or cash flows. The Company obtained $0.6 million in additional right-of-use assets in exchange for lease obligations during the three months ended March 31, 2023. The Company has made the accounting policy election to use certain ongoing practical expedients made available by ASC 842 to: (i) not separate lease components from nonlea se components for real estate; and (ii) exclude leases with an initial term of 12 months or less (“short-term” leases) from the consolidated balance sheets and will recognize related lease payments in the consolidated statements of operations on a straight-line basis over the lease term. For leases that do not have a readily determinable implicit rate, the Company uses its estimated secured incremental borrowing rate based on the information available at the lease commencement date to determine the present value of lease payments. Rent expense, including short-term lease cost, was $0.5 million and $0.4 million for the three months ended March 31, 2023 and 2022, respectively. In addition to rent payments, the Company’s leases include real estate taxes, common area maintenance, utilities, and management fees, which are not fixed. The Company accounts for these costs as variable payments and does not include such costs as a lease component. Total variable expense was not material for the three months ended March 31, 2023 and 2022. There were no leases that had not yet commenced as of March 31, 2023, that will create significant additional rights and obligations for the Company. Information related to the Company right-of-use assets and related operating lease liabilities were as follows (in thousands): Three Months Ended March 31, 2023 2022 Cash paid for operating lease liabilities $ 454 $ 261 Operating lease cost $ 512 $ 263 Non-cash right-of-use assets obtained in exchange for new operating lease obligations $ 590 $ 1,391 Weighted-average remaining lease term 4.96 years 2.06 years Weight-average discount rate 4.25% - 7.75% 4.25 % Right-of-use assets and lease liabilities consisted of the following (in thousands): March 31, 2023 December 31, 2022 Assets: Operating lease right-of-use assets $ 6,537 $ 6,381 Liabilities: Operating lease liabilities - current 1,477 1,305 Operating lease liabilities - noncurrent 5,248 5,263 Total lease liabilities $ 6,725 $ 6,568 Maturities of lease liabilities are as follows (in thousands): Remainder of fiscal year 2023 $ 1,422 Fiscal year 2024 1,532 Fiscal year 2025 1,239 Fiscal year 2026 1,183 Fiscal year 2027 1,218 Thereafter 1,125 $ 7,719 Less imputed interest 994 Total lease liabilities $ 6,725 |
SHARE BASED COMPENSATION
SHARE BASED COMPENSATION | 3 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
SHARE BASED COMPENSATION | SHARE BASED COMPENSATION: Equity Incentive Plans The Navitas Semiconductor Limited 2020 Equity Incentive Plan, initially adopted by the Company’s board of directors on August 5, 2020 as an amendment and restatement of the 2013 Equity Incentive Plan (“2013 Plan”), was amended and restated at the Closing of the Business Combination as the Amended and Restated Navitas Semiconductor Limited 2020 Equity Incentive Plan (the “2020 Plan”). The 2020 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock unit (“RSU”) awards, stock appreciation rights, and other stock awards to employees, directors and consultants. Pursuant to the 2020 Plan, the exercise price for incentive stock options and non-statutory stock options is generally at least 100% of the fair market value of the underlying shares on the date of grant. Options generally vest over 48 months measured from the date of grant. Options generally expire no later than ten years after the date of grant, subject to earlier termination upon an optionee’s cessation of employment or service. Under the terms of the 2020 Plan, the Company is authorized to issue 18,899,285 shares of common stock pursuant to awards under the 2020 Plan. As of October 19, 2021, the Company had issued an aggregate of 11,276,706 stock options and non-statutory options to its employees and consultants and 4,525,344 RSUs to employees, directors and consultants under the 2020 Plan. No awards have or will be issued under the 2020 Plan after October 19, 2021. Shares of Common Stock subject to awards under the 2020 Plan that are forfeited, expire or lapse after October 19, 2021 will become authorized for issuance pursuant to awards under the 2021 Plan (as defined below). The Navitas Semiconductor Corporation 2021 Equity Incentive Plan (the “2021 Plan”) was adopted by the Company’s board of directors on August 17, 2021 and adopted and approved by the Company’s stockholders on October 12, 2021. Under the terms of the 2021 Plan, the Company is authorized to issue, pursuant to awards granted under the 2021 Plan, (a) up to 16,334,527 shares of Common Stock; plus (b) up to 15,802,050 shares of Common Stock subject to awards under the 2020 Plan that are forfeited, expire or lapse after October 19, 2021; plus (c) an annual increase, effective as of the first day of each fiscal year up to and including January 1, 2031, equal to the lesser of (i) 4% of the number of shares of Common Stock outstanding as of the conclusion of the Company’s immediately preceding fiscal year, or (ii) such amount, if any, as the board of directors may determine. As of March 31, 2023 the Company has issued 9,750,000 non-statutory stock options under the 2021 Plan. Stock-Based Compensation At the Closing of the Business Combination on October 19, 2021, Legacy Navitas’ outstanding vested and unvested share-based compensation awards (as such terms are defined below) were converted into equity, RSUs or options in the Company at a ratio of 1.0944 to 1 share (the “Exchange Ratio”). Share and per share information below has been converted from historical disclosures based on the Exchange Ratio. The Company recognizes the fair value of stock-based compensation in its financial statements over the requisite service period of the individual grants, which generally equals a four-year vesting period, except for long-term incentive performance stock options (“LTIP Options”) discussed below. The Company uses estimates of volatility, expected term, risk-free interest rate and dividend yield in determining the fair value of these awards and the amount of compensation expense to recognize. The Company uses the straight-line method to amortize stock awards granted over the requisite service period of the award, which may be explicit or derived, unless market or performance conditions result in a graded attribution. The following table summarizes the stock-based compensation expense recognized for the three months ended March 31, 2023 and 2022: Three Months Ended March 31, 2023 2022 Research and development $ 7,177 $ 7,494 Selling, general and administrative 9,983 17,832 Total stock-based compensation expense $ 17,160 $ 25,326 Stock Options Generally, stock options granted under the Plans have terms of ten years and vest in 1/4th increments on the anniversary of the vesting commencement date and in 1/48th increments monthly thereafter. Stock options with performance vesting conditions begin to vest upon achievement of the performance condition. Expense is recognized beginning in the period in which performance is considered probable. The fair value of incentive stock options and non-statutory stock options issued was estimated using the Black-Scholes model. The Company did not grant any stock option awards during either the three months ended March 31, 2023 or 2022. A summary of stock options outstanding, excluding LTIP Options as of March 31, 2023, and activity during the three months then ended, is presented below: Stock Options Shares Weighted- Weighted- Outstanding at December 31, 2022 6,775 $ 0.59 6.20 Granted — — — Exercised (512) 0.44 — Forfeited or expired (136) 1.06 — Cancelled — — — Outstanding at March 31, 2023 6,127 $ 0.61 6.20 Vested and Exercisable at March 31, 2023 5,015 $ 0.51 5.90 During both the three months ended March 31, 2023 and 2022, the Company recognized $0.1 million of stock-based compensation expense for the vesting of outstanding stock options, excluding $2.5 million and $1.4 million related to the LTIP Options d escribed below. At March 31, 2023, unrecognized compensation cost related to unvested awards totaled $0.5 million. The weighted-average period over which this remaining compensation cost will be recognized is 1.2 years . Long-term Incentive Plan Stock Options The Company awarded a total of 6,500,000 LTIP Options to certain members of senior management on December 29, 2021 pursuant to the 2021 Plan. These non-statutory options are intended to be the only equity awards for the recipients over the duration of the performance period. The options vest in increments subject to achieving certain performance conditions, including ten share price hurdles ranging from $15 to $60 per share, coupled with revenue and EBITDA targets, measured over a seven-year performance period and expire on the tenth anniversary of the grant date. The options have an exercise price of $15.51 per share and the average fair value on the grant date was $8.13 based on the Black-Scholes model and a Monte Carlo simulation incorporating 500,000 scenarios. The weighted average contractual period remaining is 8.8 years. The Company utilized the services of a professional valuation firm to finalize these assumptions during the fiscal year ended December 31, 2022. The valuation model utilized the following assumptions: Risk-free interest rates 1.47 % Expected volatility rates 58 % Expected dividend yield — Cost of equity (for derived service period) 9.96 % Weighted-average grant date fair value of options $ 8.13 In connection with LTIP Options granted in 2021, the Company recognized $2.2 million and $1.4 million of stock-based compensation expense for the three months ended March 31, 2023 and 2022, respectively. The unrecognized compensation expense related to these LTIP Options is $51.6 million as of M arch 31, 2023, and compensation expense will be recogn ized over 3.2 years. The Company awarded a total of 3,250,000 LTIP Options to a member of senior management on August 15, 2022 pursuant to the 2021 Plan. The options vest in increments subject to achieving certain market and performance conditions, including ten share price hurdles ranging from $15 to $60 per share, coupled with revenue and EBITDA targets, measured over a seven year performance period and expire on the tenth anniversary of the grant date. The options have an exercise price of $10.00 per share and the average fair value on the grant date was $2.51. The weighted average contractual period remaining is 9.4 years. T he Black-Scholes model and a Monte Carlo simulation incorporated 100,000 scenarios. The valuation model utilized the following assumptions: Risk-free interest rates 2.82 % Expected volatility rates 63 % Expected dividend yield — Cost of equity (for derived service period) 14.64 % Weighted-average grant date fair value of options $ 2.51 In connection with LTIP Options granted in 2022, the Company recognized $0.3 million of stock-based compensation expense for the three months ended March 31, 2023. The unrecognized compensation expense related to the LTIP Options is $8.7 million as of March 31, 2023, and compensation expense will be recognized over 3.8 years. Restricted Stock Units On August 25, 2021, the Company granted an aggregate of 4,135,000 Legacy Navitas RSUs under the 2020 Plan to certain members of senior management pursuant to restricted stock unit agreements (collectively, the “RSU Agreements”). Each RSU represents the right to receive one share of common stock of the Company, subject to the vesting and other terms and conditions set forth in the RSU Agreements and the Plan. 3,500,000 of these RSU awards vest in three equal installments over a three-year period subject to the occurrence of an IPO (which includes the Business Combination) and certain valuation targets, subject to an accelerated vesting schedule based on the satisfaction of certain stock price targets. Up to 500,000 of these RSUs were eligible to vest on the six-month anniversary of the grant date, subject to the occurrence of an IPO (which included the Business Combination) and certain valuation targets. 52,500 RSUs vested upon the occurrence of the Business Combination, while the remaining 82,500 RSUs vest as specified by an RSU Agreement over a period of approximately three years. As of October 19, 2021, the IPO performance condition had been met due to the Business Combination. Additionally, the Company regularly grants RSUs to employees as a component of their compensation. A summary of RSUs outstanding as of March 31, 2023 , and activity during the three months then ended, is presented below: Shares Weighted-Average Grant Date Fair Value Per Share Outstanding at December 31, 2022 11,606 $ 5.93 Granted 5,392 6.15 Vested (1,707) 7.46 Forfeited (67) 6.62 Outstanding at March 31, 2023 15,224 $ 6.30 During the three months ended March 31, 2023 and 2022 , the Company recognized $7.1 million and $16.2 million of stock-based compensation expense for the vesting of RSUs, respectively. As of March 31, 2023, unrecognized compensation cost related to unvested RSU awards totaled $90.2 million. The weighted-average period over which this remaining compensation cost is expected be recognized is 2.8 years. The Company implemented a yearly a stock-based bonus plan in 2021 which settles by issuing a variable number of fully-vested restricted stock units to employees in the first quarter of the following fiscal year. The $2.3 million accrued as of March 31, 2023 reflects eligible employees included the Company’s 2023 annual bonus plan and amounts expected to be settled during the first quarter of 2024. The $2.8 million accrued as of December 31, 2022 was for the Company’s 2022 annual bonus plan and a balance of $0.1 million is accrued as of March 31, 2023. Other Share Awards In connection with the acquisition of the remaining minority interest of a silicon control IC joint venture, as described in Note 18, the Company issued 841,729 fully vested shares to certain former employees of the joint venture with a grant date fair value totaling $4.5 million. Such amount has been recognized as stock-based compensation expense during the three months ended March 31, 2023. Unvested Earnout Shares A portion of the earnout shares related to the Business Combination (discussed in Note 11 below) may be issued to individuals with unvested equity awards. While the payout of these shares requires achievement of share price targets based on the volume weighted average price of the Company’s common stock, the individuals are required to complete the remaining service period associated with these unvested equity awards to be eligible to receive the earnout shares. As a result, these unvested earn-out shares are equity-classified awards and have an aggregated grant date fair value of $19.1 million or $11.52 per share. During the three months ended March 31, 2023 and 2022 the Company recog nized $0.3 million and $6.3 million, respectively, of s tock-based compensation expense for the vesting of earnout shares. At March 31, 2023, there was no remaining compensation cost related to unvested earnout shares. Refer to Note 11, Earnout Liability. |
WARRANT LIABILITY
WARRANT LIABILITY | 3 Months Ended |
Mar. 31, 2023 | |
Warrants and Rights Note Disclosure [Abstract] | |
WARRANT LIABILITY | WARRANT LIABILITY In connection with the closing of the Business Combination, holders of Live Oak Class A ordinary shares automatically received Class A Common Stock of the Company, and holders of Live Oak warrants automatically received a total of 13,100,000 warrants of the Company with substantially identical terms (“the Warrants”). Accordingly, 8,433,333 Live Oak public warrants automatically converted into 8,433,333 warrants to purchase one share of the Company’s Class A Common Stock at $11.50 per share (the “Public Warrants”), and 4,666,667 private placement warrants held by the sponsor of the Business Combination and certain permitted transferees (“Private Placement Warrants”), each exercisable for one Class A ordinary share of Live Oak at $11.50 per share, automatically converted into warrants to purchase one share of the Company’s Class A Common Stock at $11.50 per share with substantially identical terms as the Public Warrants. On February 4, 2022, the Company gave notice that it would redeem all of the Warrants, as further described below. The Warrants were exercisable only during the period commencing December 7, 2021 (12 months after the consummation of Live Oak’s initial public offering) and ending on the earlier of October 19, 2026 (five years after the Closing of the Business Combination) or, in the event of redemption, the corresponding redemption date. The Company had the right to redeem not less than all of the outstanding Public Warrants on 30 days’ notice, at a redemption price of $0.01 per Warrant, if the reported closing price of the Common Stock was at least $18.00 per share for any 20 of 30 trading days ending three three three ers of Warrants subject to redemption would have the right to exercise their Warrants on a “cashless” basis, whereby they would receive a fractional number of shares of Common Stock per Warrant exercised before the redemption date, based on the volume weighted average price of the Common Stock for the 10 trading days following notice of redemption (the “Redemption Fair Market Value”) and the time period between the redemption date and the original expiration date of the Warrants in the absence of redemption. On February 4, 2022, the Company issued a notice of redemption that it would redeem, at 5:00 p.m. New York City time on March 7, 2022 (the “ Redemption Date ”), all of the Company’s outstanding Public Warrants and Private Placement Warrants to purchase shares of the Company’s Class A Common Stock that were governed by the Warrant Agreement, dated as of December 2, 2020 (the “ Warrant Agreement ”), between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agent”), at a redemption price of $0.10 per Warrant (the “ Redemption Price ”). On February 22, 2022, the Company issued a notice that the “Redemption Fair Market Value,” determined in accordance with the Warrant Agreement based on the volume weighted average price of the Common Stock for the 10 trading days immediately following the date on which notice of redemption was sent, was $10.33 and, accordingly, that holders exercising Warrants on a “cashless” basis before the Redemption Date would receive 0.261 shares of Common Stock per Warrant exercised. The Warrants were exercisable by their holders until immediately before 5:00 p.m. New York City time on the Redemption Date, either (i) on a cash basis, at an exercise price of $11.50 per share of Common Stock, or (ii) on a “cashless” basis in which the exercising holder would receive 0.261 shares of Common Stock per Warrant exercised. Between December 7, 2021 (the date the Warrants became exercisable) and the Redemption Date, an aggregate of 12,722,773 Warrants were exercised (including 17,785 on a cash basis and 12,704,988 on a “cashless” basis); an aggregate of 3,333,650 shares of Common Stock were issued upon exercise of the Warrants (including 17,785 shares in respect of cash exercises and 3,315,865 shares in respect of “cashless” exercises). A total of 377,187 Warrants remained outstanding and unexercised at the Redemption Date and were redeemed for an aggregate Redemption Price of $38. Prior to the Redemption Date, the warrants had an aggregate fair value of $81.4 million which resulted in a gain of $51.8 million due to the decrease in the fair value of the warrant liability in the three months ended March 31, 2022. There were no outstanding warrants as of March 31, 2023. |
EARNOUT LIABILITY
EARNOUT LIABILITY | 3 Months Ended |
Mar. 31, 2023 | |
Warrants and Rights Note Disclosure [Abstract] | |
EARNOUT LIABILITY | EARNOUT LIABILITY Certain of the Company’s stockholders are entitled to receive up to 10,000,000 “earnout shares” of the Company’s Class A Common Stock if the earnout milestones are met. The earnout milestones represent three independent criteria, each of which entitles the eligible stockholders to 3,333,333 aggregate earn-out shares if the milestone is met. Each earnout milestone is considered met if at any time 150 days following the Business Combination and prior to October 19, 2026, the volume weighted average price of the Company’s Class A Common Stock is greater than or equal to $12.50, $17.00 or $20.00, respectively, for any twenty trading days within any thirty trading day period, respectively. Further, the earnout milestones are also considered to be met if the Company undergoes a Sale. A Sale is defined as the occurrence of any of the following: (i) engaging in a “going private” transaction pursuant to Rule 13e-3 under the Exchange Act or otherwise ceasing to be subject to reporting obligations under Sections 13 or 15(d) of the Exchange Act; (ii) the Class A Common Stock ceases to be listed on a national security exchange, other than for the failure to satisfy minimum listing requirements under applicable stock exchange rules; or (iii) a change of ownership (including a merger or consolidation) or approval of a plan for complete liquidation or dissolution. These earnout shares have been categorized into two components: (i) the “Vested Shares” – those associated with vested equity held by stockholders at the closing of the Business Combination that will be earned upon achievement of the earnout milestones and (ii) the “Unvested Shares” – those associated with unvested equity held by stockholders at the closing of the Business Combination that will be earned over the remaining service period with the Company on their Unvested Shares and upon achievement of the earnout milestones. The Vested Shares are classified as liabilities in the consolidated balance sheet and the Unvested Shares are equity-classified share-based compensation to be recognized over time (see Note 9, Share-based Compensation). The earnout liability was initially measured at fair value at the closing of the Business Combination and subsequently remeasured at the end of each reporting period. The change in fair value of the earn-out liability is recorded as part of Other income (expense), net in the consolidated statements of operations. The estimated fair value of the earnout liability was determined using a Monte Carlo analysis of 20,000 simulations of the future path of the Company’s stock price over the earnout period. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones including projected stock price, volatility, and risk-free rate. The valuation model utilized the following assumptions: March 31, 2023 December 31, 2022 Risk-free interest rate 3.75 % 4.13 % Equity volatility rate 63.00 % 65.00 % At the closing of the Business Combination on October 19, 2021, the earnout liability had an initial fair value of $96.1 million, which was recorded as a long-term liability and a reduction to additional paid in capital in the consolidated balance sheets. As of March 31, 2023 and December 31, 2022, the earnout liability had a fair value of $40.4 million and $12.5 million, respectively which resulted in a loss in the fair value of the earnout liability of $27.9 million for the three months ended March 31, 2023 due to the increase in the fair value of the earnout liability. GeneSiC Earnout Liability In connection with the acquisition of GeneSiC as discussed in Note 17, the Company will pay additional contingent consideration of up to $25.0 million, in the form of cash earnout payments to the Sellers and certain employees of GeneSiC, conditioned on the achievement of substantial revenue and gross profit margin targets for the GeneSiC business over the four fiscal quarters beginning on October 1, 2022 and ending on September 30, 2023. The estimated fair value of the earnout liability was determined using a Monte Carlo analysis of 20,000 simulations assuming that GeneSiC’s revenue and gross profit margins follow a geometric Brownian motion over the earnout period. The valuation model utilized an assumption on the risk-free interest rate of 3.1% and equity volatility rate of 99.9%. As of March 31, 2023, the GeneSiC earnout probability is considered remote, and a liability of $0.4 million is recorded in earnout liability in the Company’s Condensed Consolidated Balance Sheets. |
SIGNIFICANT CUSTOMERS AND CREDI
SIGNIFICANT CUSTOMERS AND CREDIT CONCENTRATIONS | 3 Months Ended |
Mar. 31, 2023 | |
Risks and Uncertainties [Abstract] | |
SIGNIFICANT CUSTOMERS AND CREDIT CONCENTRATIONS | SIGNIFICANT CUSTOMERS AND CREDIT CONCENTRATIONS Customer Concentration A majority of the Company’s revenues are attributable to sales of the Company’s products to distributors of electronic components. These distributors sell the Company’s products to a range of end users, including OEMs and merchant power supply manufacturers The following customers represented 10% or more of the Company’s net revenues for the three months ended March 31, 2023 and 2022: Three Months Ended March 31, Customer 2023 2022 Distributor A 35 % * Distributor B 19 * Distributor C 17 31 % Distributor D * 39 Distributor E * 13 *Total customer net revenues was less than 10% of total net revenues. Revenues by Geographic Area The Company considers the domicile of its end customers, rather than the distributors it sells to directly, to be the basis for attributing revenues from external customers to individual countries. Revenues for the three months ended March 31, 2023 and 2022 were attributable to end customers in the following countries or regions: Three Months Ended March 31, Country 2023 2022 Europe* 28 % — China 57 58 % United States 11 33 Rest of Asia 4 9 All others — — Total 100 % 100 % *Impractical to disclose the revenue percentages by individual countries within Europe and therefore Europe is presented in total. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consisted principally of cash, cash equivalents and trade receivables. The Company maintains its cash and cash equivalents with high-credit quality financial institutions. At times, such amounts may exceed federally insured limits. The Company has not experienced any losses on cash or cash equivalents held at financial institutions. The Company does not have any off-balance-sheet credit exposure related to its customers. The following customers represented 10% or more of the Company’s accounts receivable. Customer March 31, 2023 December 31, 2022 Distributor A 32 % 19 % Distributor B 19 25 Distributor C 11 * *Total customer accounts receivable was less than 10% of total net accounts receivable. Concentration of Supplier Risk The Company currently relies on a single foundry to produce wafers for GaN ICs and a separate single foundry to produce wafers for SiC MOSFETs. Loss of the relationship with either of these suppliers could have a substantial negative |
NET INCOME (LOSS) PER SHARE
NET INCOME (LOSS) PER SHARE | 3 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
NET INCOME (LOSS) PER SHARE | NET INCOME (LOSS) PER SHARE: Basic income (loss) per share is calculated by dividing net income (loss) by the weighted-average shares of common stock outstanding during the period. Diluted earnings per share are calculated by dividing net income (loss) by the weighted-average shares of common stock and dilutive common equivalent shares outstanding during the period. Dilutive common equivalent shares included in this calculation consist of dilutive shares issuable upon the assumed exercise of outstanding common stock options, the assumed vesting of outstanding restricted stock units and restricted stock awards, the assumed issuance of awards for contingently issuable performance-based awards, as computed using the treasury stock method. Performance-based restricted stock units and restricted stock awards are included in the number of shares used to calculate diluted earnings per share after evaluating the applicable performance criteria as of period end and under the assumption the end of the reporting period was the end of the contingency period, and the effect is dilutive. Restricted stock awards (but not restricted stock unit awards) are eligible to receive all dividends declared on the Company’s common shares during the vesting period; however, such dividends are not paid until the restrictions lapse. The Company has no plans to declare dividends. A summary of the net income (loss) per share calculation is as follows (in thousands, except per share amounts): Three Months Ended March 31, Numerator - basic and diluted: 2023 2022 Net income (loss) attributable to controlling interests $ (61,847) $ 79,792 Denominator Weighted-average common shares - basic common stock 156,792 119,542 Weighted-average common shares - diluted common stock 156,792 131,149 Net income (loss) per share - basic common stock $ (0.39) $ 0.67 Net income (loss) per share - diluted common stock $ (0.39) $ 0.61 Denominator Weighted-average common shares - basic common stock 156,792 119,542 Stock options and other dilutive awards — 11,607 Weighted-average common shares - diluted common stock 156,792 131,149 Shares excluded from diluted weighted-average shares: 1 Earnout shares (potentially issuable common shares) 10,000 10,000 Unvested restricted stock units and restricted stock awards 376 4,979 Stock options potentially exercisable for common shares 9,750 6,500 Shares excluded from diluted weighted average shares 20,126 21,479 (1) The Company’s potentially dilutive securities, which include unexercised stock options, unvested shares, preferred shares, earnout shares, and warrants for common and preferred shares, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share for the three months ended March 31, 2023. |
PROVISION FOR INCOME TAXES
PROVISION FOR INCOME TAXES | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
PROVISION FOR INCOME TAXES | PROVISION FOR INCOME TAXES: Income Taxes The Company determined the income tax provision for interim periods using an estimate of the Company’s annual effective tax rate, adjusted for discrete items arising during the quarter. The Company’s effective tax rate for the three months ended March 31, 2023 and 2022 was (0.03)% and 0.0%, respectively. The effective tax rate was impacted by nondeductible executive compensation and other expenses, stock compensation, state taxes, and the change in valuation allowance in the U.S. and certain foreign jurisdictions. The effective tax rate for 2023 differs from the prior year primarily as a result of tax expense in certain foreign jurisdictions not impacted by valuation allowance. The effective tax rate as of March 31, 2022 is reflective of a full valuation allowance in all jurisdictions. The Company’s quarterly income tax provision and quarterly estimate of the annual effective tax rate are subject to volatility due to several factors, including our ability to accurately predict the proportion of our income (loss) before provision for income taxes in multiple jurisdictions, the tax effects of stock-based compensation, and the effects of its foreign entities. The Company had no unrecognized tax benefits for the three months ended March 31, 2023 and 2022. The Company recognizes interest and penalties related to unrecognized tax benefits in operating expenses. No such interest and penalties were recognized during the three months ended March 31, 2023 and 2022. |
COMMITMENTS and CONTINGENCIES
COMMITMENTS and CONTINGENCIES | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS and CONTINGENCIES | COMMITMENTS and CONTINGENCIES Purchase Obligations At March 31, 2023, the Company had no non-cancelable contractual arrangements that were due beyond one year besides lease obligations. Employment agreements The Company has entered into agreements with certain employees to provide severance payments to the employees for termination for reasons other than cause, death or dis ability. Aggregate payments that would be required to be made in the event of termination under the agreements are approximately $2.1 million. A t March 31, 2023, no terminations have occurred or are expected to occur pursuant to these arrangements and, accordingly, no termination benefits have been accrued. Indemnification The Company sells products to its distributors under contracts, collectively referred to as Distributor Sales Agreements (“DSAs”). Each DSA contains the relevant terms of the contractual arrangement with the distributor, and generally includes certain provisions for indemnifying the distributor against losses, expenses, and liabilities from damages that may be awarded against the distributor in the event the Company’s products are found to infringe upon a patent, copyright, trademark, or other proprietary right of a third party (Customer Indemnification). The DSA generally limits the scope of and remedies for the Customer Indemnification obligations in a variety of industry-standard respects, including, but not limited to, limitations based on time and geography, and a right to replace an infringing product. The Company also, from time to time, has granted a specific indemnification right to individual customers. The Company believes its internal development processes and other policies and practices limit its exposure related to such indemnifications. In addition, the Company requires its employees to sign a proprietary information and inventions agreement, which assigns the rights to its employees’ development work to the Company. To date, the Company has not had to reimburse any of its distributors or end customers for any losses related to these indemnifications and no material claims were outstanding as of March 31, 2023. For several reasons, including the lack of prior indemnification claims and the lack of a monetary liability limit for certain infringement cases, the Company cannot determine the maximum amount of potential future payments, if any, related to such indemnifications. Legal proceedings and contingencies From time to time in the ordinary course of business, the Company may become involved in lawsuits, or end customers, distributors, suppliers or other third parties may make claims against the Company. The Company makes a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company is not currently subject to any pending actions or regulatory proceedings that either individually or in the aggregate are expected to have a material impact on its condensed consolidated financial statements. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | RELATED PARTY TRANSACTIONS Notes Receivable The Company had outstanding interest-bearing notes receivable from an employee. The notes had various maturity dates through May 1, 2023 and bore interest at rates ranging from 1% to 2.76%. As of December 31, 2022, Note 1 was forgiven for a loss of $0.1 million and Note 2 was paid off in the amount of $0.1 million. The Company did not recognize significant interest income from the notes for the three months ended March 31, 2023 or 2022. Joint Venture In 2021, Navitas entered into a silicon control IC joint venture with Halo Microelectronics Co., Ltd. (“Halo”), a manufacturer of power management ICs, to develop products and technology relating to AC/DC converters. Navitas’ initial contribution to the joint venture was the commitment to sell its GaN integrated circuit die at prices representing cost plus insignificant handling fees, in exchange for a minority interest, with the right to acquire the balance of the joint venture based on the future results of the venture (among other rights and obli gat ions). On January 19, 2023, the Company announced an agreement to acquire the remaining minority interest in the joint venture as well as rights to certain intellectual property from Halo and its U.S. affiliate for a total purchase price of $22.4 million in Navitas stock. Total related party revenues recognized by the Company as a result of arrangements with its joint venture were $0.0 million and $0.6 million for the three months ended March 31, 2023 and 2022 , respectively, and are included in Net Revenues in the Condensed Consolidated Statements of Operations. See Note 18, Noncontrolling Interest, for more information. Related Party Investment During the third quarter of 2022, Navitas ma de a $1.5 million inv estment in preferred interests of an entity under common control with the Company’s partner in the joint venture described above. During the first quarter of 2023 the Company made an additional investment of $1.0 million in the entity. Such investment is included in Other Assets in the Condensed Consolidated Balance Sheets as of March 31, 2023 and is accounted for as an equity investment under ASC 321 Investments - Equity Securities . In accordance with ASC 321, the Company elected to use the measurement alternative to measure such investments at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer, if any. Related Party Advance During the third quarter of 2022, Navitas made a $1.0 million advance to its p artner in the joint venture described above in order to facilitate orders of raw materials. The outstanding amount as of March 31, 2023 was not material. Related Party Leases The Company leases certain property from an entity that it is owned by an executive of the Company, which expires in September 2023. During the three months ended March 31 2023, the Company paid an immaterial amount in rental payments in relation to this lease. These payments were made at standard market rates in the ordinary course of business. The total rent obligation as of March 31, 2023 was $0.1 million through September 30, 2023. The Company leases certain property from the family member of a senior executive of the Company, which expires in March 2024. During the three months ended March 31 2023, the Company paid an immaterial amount in rental payments in relation to this lease. These payments were made at standard market rates in the ordinary course of business. The total rent obligation as of March 31, 2023 was $43 thousand through March 31, 2024. |
BUSINESS COMBINATIONS
BUSINESS COMBINATIONS | 3 Months Ended |
Mar. 31, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
BUSINESS COMBINATIONS | BUSINESS COMBINATIONS Acquisition of VDDTECH srl On June 10, 2022, the Company’s wholly owned subsidiary, Navitas Semiconductor Limited, acquired all of the stock of VDDTECH srl, a private Belgian company (“VDDTech”) for approximately $1.9 million in cash and stock. Based in Mont-saint-Guibert, Belgium, VDDTech creates advanced digital-isolators for next-generation power conversion. VDDTech’s net assets and operating results since the acquisition date are inc luded in the Company’s Condensed Consolidated Statements of Operations and were not material for the three months ended March 31, 2022. Among shares issued in the transaction, the Company issued approximately 113,000 restricted shares that are subject to time based vesting and issued approximately 151,000 restricted shares that are subject to time and performance based vesting over the next four The Company recorded an allocation of the purchase price to tangible assets acquired and liabilities assumed based on their fair values as of the acquisition date. The excess of the purchase price over the fair value of tangible assets and liabilities of $1.2 million was recorded as goodwill as of June 30, 2022. Subsequent to June 30, 2022, a valuation of the intangible assets acquired was calculated at $1.2 million . During the third quarter of fiscal year 2022, the Company reclassified the goodwill to an intangible asset. The fair value of the in-process R&D was estimated using the multi-period excess earnings method, an income approach (Level 3), which converts projected revenues and costs into cash flows. To reflect the fact that certain other assets contribute to the cash flows generated, the returns for these contributory assets were removed to arrive at estimated cash flows solely attributable to the acquired technology, which were discounted at a rate of 18% to determine the fair value. Acquisition of GeneSiC Semiconductor Inc. On August 15, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) to acquire 100% of the outstanding shares of GeneSiC Semiconductor Inc., a silicon carbide (“SiC”) pioneer with deep expertise in SiC power device design and process, based in Dulles, Virginia. Total merger consideration was approximately $244.0 million and consisted of approximately $146.3 million of common stock, $97.1 million of cash consideration, and potential future cash earn-out payments of up to an aggregate of $25.0 million which were fair valued at $0.6 million. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The Company has determined fair values of the assets acquired and liabilities assumed. These values are subject to change as the Company performs additional reviews of the assumptions used. The following tables summarize the purchase consideration and the purchase price allocation to estimated fair values of the identifiable assets acquired and liabilities assumed (in thousands): Merger Consideration Fair Value Cash consideration at closing $ 97,116 Equity consideration at closing 146,314 Contingent earn-out 600 Total $ 244,030 Estimate of purchase price allocation Cash and cash equivalents $ 951 Accounts receivable 823 Inventory 1,539 Fixed assets 226 Other assets 5 Intangible assets 110,100 Goodwill 157,699 Total assets acquired $ 271,343 Liabilities assumed: Interest bearing debt 16 Other current liabilities 2,749 Deferred tax liabilities 24,548 Total liabilities acquired 27,313 Estimated fair value of net assets acquired $ 244,030 Goodwill represents the excess of the merger price over the amounts assigned to the fair value of the assets acquired and the liabilities assumed, the final amount of the goodwill recorded could differ materially from the amount presented. Goodwill is primarily attributable to assembled workforce, market and expansion capabilities, expected synergies from integration and streamlining operational activities and other factors. Goodwill is not expected to be deductible for income tax purposes. The fair values of the identifiable intangible assets acquired at the date of Acquisition are as follows (in thousands): Intangible Asset Fair Value Amortization Method Useful Life Trade Names $ 900 Straight line 2 years Developed Technology 49,100 Straight line 4 years Patents 33,900 Straight line 15 years Customer Relationships 24,300 Straight line 10 years Non-Competition Agreements 1,900 Straight line 5 years Total Intangibles $ 110,100 The valuations of intangible assets incorporate significant unobservable inputs and require significant judgment and estimates, including the amount and timing of future cash flows. The Company recognized approximately $5.9 million of transaction costs in the fiscal year ended December 31, 2022. These costs were recorded in “Selling, general and administrative expense” in the consolidated statements of operations. The financial results of GeneSiC have been included in the Company's consolidated financial statements since the date of the acquisition. The fair value of developed technology was estimated using the multi-period excess earnings method, an income approach (Level 3), which converts projected revenues and costs into cash flows. To reflect the fact that certain other assets contribute to the cash flows generated, the returns for these contributory assets were removed to arrive at estimated cash flows solely attributable to the acquired technology, which were discounted at a rate of 15% to determine the fair value. The fair value of customer relationships was estimated using the distributor method, an income level approach (Level 3), which estimates the value of an asset based upon costs avoided through ownership of the asset. Estimated costs on projected revenues were made using historical data pertaining to sales to new and existing customers. The cash flow impact of projected cost savings, primarily avoidance of legal costs pertaining to new customers and lower commission rates applicable to existing customers than new customers, were discounted at a rate of 16% to determine the fair value. The fair value of the trade name and trademarks was estimated using the relief from royalty method, an income approach (Level 3), because of the licensing appeal of these assets, the Company estimated the benefit of the ownership as the relief from the royalty expense that would be incurred in the absence of ownership A royalty rate was applied to the projected revenues associated with the intangible asset to determine the amount of savings, which was at a rate of 1% to determine the fair value. The fair value of the patents was estimated using the relief from royalty method, an income approach (Level 3), because of the licensing appeal of these assets, the Company estimated the benefit of the ownership as the relief from the royalty expense that would be incurred in the absence of ownership. A royalty rate was applied to the projected revenues associated with the intangible asset to determine the amount of savings, which was at a rate of 5% to determine the fair value. The value of the non-competition agreement was estimated using the lost income method (Level 3). Because the non-competition agreement prohibits the covenantor from competing with the Company, the fair value of the non-competition agreement can be determined by estimating cash flows that would be lost if the covenantors were to compete. Based on this method we estimated a discount rate of 16% to determine the fair value. Discount rates for each respective intangible asset were determined by accounting for the risk associated with each asset, including required technology development and customer acquisition required to support respective projections, the uncertainty of market success and the risk inherent with projected financial results. The estimated useful lives were determined by evaluating the expected economic and useful lives of the assets and of similar intangible assets from comparable business combinations and adjusting accordingly after taking into account circumstances that may be unique to GeneSiC. Net tangible assets and intangibles assets assumed as well as goodwill recognized are presented as continuing operations in the consolidated balance sheets. The following unaudited pro forma financial information presented in the table below is provided for illustrative purposes only and is based on the historical financial statements of the Company and presents the Company’s results as if the business combination had occurred as of January 1, 2022 (in thousands): UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2022 Revenue $ 11,476 Net income $ 79,741 Basic net income per share $ 0.55 Diluted net income per share $ 0.51 The unaudited pro forma financial information may not be indicative of the results of operations that the Company would have attained had the business combination occurred as of January 1, 2022, nor is the pro forma financial information indicative of the results of operations that may occur in the fut ure. |
NONCONTROLLING INTEREST
NONCONTROLLING INTEREST | 3 Months Ended |
Mar. 31, 2023 | |
Noncontrolling Interest [Abstract] | |
NONCONTROLLING INTEREST | NONCONTROLLING INTEREST In July 2021, the Company formed a joint venture for the purpose of conducting research and development on technology in the area of AC/DC converters for chargers and adapters. Refer to Note 16 above. On August 19, 2022, the Company obtained control of the joint venture, and no consideration was paid pursuant to the Change of Control Agreement. The Company consolidated the fair value of the net assets of the joint venture as of August 19, 2022, and the Company reports noncontrolling interests of the joint venture as a component of equity separate from the Company’s equity. The fair value of the noncontrolling interest and net assets is based on estimates. The Company’s net income (loss) excludes income (loss) attributable to the noncontrollling interests. The fair value of the joint venture was determined based on a multiple of future annual revenues with a discount rate of 30%. In connection with the consolidation, the Company reacquired a patent license, which was fair valued at $1.0 million based on comparable transactions during the year, and will be amortized over a five year term. Goodwill of $3.1 million was recorded in connection with this transaction On January 19, 2023, the Company announced an agreement to acquire the remaining minority interest in the joint venture as well as rights to certain intellectual property from Halo and its U.S. affiliate for a total purchase price of $22.4 million in Navitas stock. The transaction was completed on February 13, 2023. In connection with the purchase of intellectual property, the Company recognized developed technology as an intangible asset at its estimated fair value o f $4.4 million . As a result of this transaction, the Company recorded a net increase to additional paid in capital of $7.5 million representing the difference between the fair value of share consideration related to the acquisition of the remaining noncontrolling interest and the carrying value of the noncontrolling interest at the date of the transaction. The fair value of the developed technology was estimated using the relief from royalty method, an income approach (Level 3), because of the licensing appeal of these assets The Company estimated the benefit of the ownership as the relief form the royalty expense that would be incurred in the absence of ownership. A royalty rate was applied to the projected revenues associated with the intangible asset to determine the amount of savings, which was at a rate of 10% to determine the fair value. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Mar. 31, 2023 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | SUBSEQUENT EVENTSThe Company evaluated material subsequent events from the consolidated balance sheet date of March 31, 2023, through May 15, 2023, the date the condensed consolidated financial statements were issued. There were no material subsequent events as of May 15, 2023. |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Consolidation | Basis of Consolidation The accompanying condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The results of operations for the three months ended March 31, 2023 shown in this report are not necessarily indicative of results to be expected for the full year ending December 31, 2023. In the opinion of the Company’s management, the information contained herein reflects all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the Company’s results of operations, financial position, cash flows and stockholders’ equity (deficit). Certain footnote disclosures normally included in annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (“SEC”) rules and regulations relating to interim financial statements. The accompanying condensed consolidated financial statements should be read in conjunction with consolidated financial statements and notes thereto contained in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on April 3, 2023. Except as further described below, there have been no significant changes in the Company’s accounting policies from those disclosed in its Form 10-K filed with the SEC on April 3, 2023. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material intercompany transactions between and among the Company and its consolidated subsidiaries have been eliminated in consolidation. The Company’s net income (loss) excluded income (loss) attributable to the noncontrolling interests. The consolidated financial statements include the accounts of Elevation Semiconductor Inc. (the “Joint Venture”), an entity in which the Company had a controlling interest since August 19, 2022 (see Note 18, Noncontrolling Interest). During the first quarter of fiscal year 2023 the Company acquired the remaining noncontrolling interest in the Joint Venture. The transaction was completed on February 13, 2023. As Navitas already had a controlling interest, financial results from the Joint Venture have already been reflected in Navitas’ historical financial statements. The condensed consolidated financial statements include the accounts of the Company, its wholly owned or majority-owned subsidiaries and entities in which the Company is deemed to have a direct or indirect controlling financial interest based on either a variable interest model or voting interest model. All intercompany transactions and balances have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. On an ongoing basis, management evaluates the assumptions used in making estimates, including those related to (i) the collectability of accounts receivable; (ii) write-down for excess and obsolete inventory; (iii) warranty obligations; (iv) the value assigned to and estimated useful lives of long-lived assets; (v) the realization of tax assets and estimates of tax liabilities and tax reserves; (vi) recoverability of intangible assets; (vii) the computation of share-based compensation; (viii) accrued compensation and other expenses; and (ix) the recognition of revenue. These estimates are based on historical data and experience, as well as various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company engages third-party valuation specialists to assist with estimates related to the valuation of intangible assets, stock options, restricted common stock awards,earnout shares and warrants. Such estimates often require the selection of appropriate valuation methodologies and models, and significant judgment in evaluating ranges of assumptions and financial inputs. Actual results could differ from those estimates. |
Business Combinations/Valuation of Contingent Consideration Resulting from a Business Combination | Business Combinations We account for business combinations using the acquisition method of accounting, in accordance with Accounting Standards Codification (“ASC”) 805 , “ Business Combinations” . The acquisition method requires identifiable assets acquired and liabilities assumed to be recognized and measured at fair value on the acquisition date, which is the date that the acquirer obtains control of the acquired business. The amount by which the fair value of consideration transferred exceeds the net fair value of assets acquired and liabilities assumed is recorded as goodwill. The determination of estimated fair value requires us to make significant estimates and assumptions. These fair value determinations require judgment and involve the use of significant estimates and assumptions, including assumptions with respect to future cash inflows and outflows, discount rates, and asset lives, among other items. As a result, we may record adjustments to the fair values of assets acquired and liabilities assumed within the measurement period (up to one year from the acquisition date) with the corresponding offset to goodwill. Transaction costs associated with business combinations are expensed as they are incurred. Valuation of Contingent Consideration Resulting from a Business Combination In connection with certain acquisitions, we may be required to pay future consideration that is contingent upon the achievement of specified milestone events. We record contingent consideration resulting from a business combination at its fair value on the acquisition date. Each quarter thereafter, we revalue these obligations and record increases or decreases in their fair value within our Condensed Consolidated Statements of Operations until such time as the specified milestone achievement period is complete. Increases or decreases in fair value of the contingent consideration liabilities can result from updates to assumptions such as the expected timing or probability of achieving the specified milestones. Significant judgment is employed in determining these assumptions as of the acquisition date and for each subsequent period. Updates to assumptions could have a significant impact on our results of operations in any given period. Actual results may differ from estimates. |
Recently Adopted Accounting Standards | Recently Adopted Accounting Standards Credit Losses In June 2016, the Financial Accounting Standards Board (“FASB”) amended guidance related to impairment of financial instruments as part of ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which replaced the incurred loss impairment methodology with an expected credit loss model for which a company recognizes an allowance based on the estimate of expected credit loss. This ASU requires entities to measure the impairment of certain financial instruments, including accounts receivable, based on expected losses rather than incurred losses. For companies that qualify under the emerging growth company exemptions, this ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted, and is effective for the Company beginning in 2023. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures. We pool financial assets based on their risk characteristics, which include class of customer, geographic location of the customer, contractual life of the financial asset, and age of the open receivable balance. The allowance for credit losses pool is estimated based on historical credit loss rates adjusted for management’s reasonable and supportable expectations of future economic conditions, which consider macroeconomic, industry and market trends that could impact future credit loss rates. Additions to the allowance are charged to general and administrative expenses in the consolidated statements of operations. Accounts receivable are written off against the allowance when the probability of collection of an account balance is deemed remote. |
INVENTORY (Tables)
INVENTORY (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory, Current | Inventory consists of the following (in thousands): March 31, 2023 December 31, 2022 Raw materials $ 3,551 $ 4,314 Work-in-process 11,609 9,166 Finished goods 3,713 5,581 Total $ 18,873 $ 19,061 |
PROPERTY AND EQUIPMENT, NET (Ta
PROPERTY AND EQUIPMENT, NET (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property, Plant and Equipment | Property and equipment, net consist of the following (in thousands): March 31, 2023 December 31, 2022 Furniture and fixtures $ 202 $ 215 Computers and other equipment 8,064 7,251 Leasehold improvements 2,045 2,054 Construction in Progress 71 — 10,382 9,520 Accumulated depreciation (3,542) (2,988) Total $ 6,840 $ 6,532 For the three months ended March 31, 2023 and 2022, depreciation expense w as $0.5 million and $0.1 million, respectively, and was determined using the straight-line method over the following estimated useful lives: Furniture and fixtures 3 — 7 years Computers and other equipment 2 — 5 years Leasehold improvements 2 — 5 years |
FAIR VALUE OF FINANCIAL ASSET_2
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value For Financial Assets And Liabilities | The following table presents the Company’s fair value hierarchy for financial liabilities as of March 31, 2023 (in thousands) : Level 1 Level 2 Level 3 Total Liabilities: Earnout liability $ — $ — $ 40,816 $ 40,816 Total $ — $ — $ 40,816 $ 40,816 The following table presents the Company’s fair value hierarchy for financial liabilities as of December 31, 2022 (in thousands): Level 1 Level 2 Level 3 Total Liabilities: Earnout liability $ — $ — $ 13,064 $ 13,064 Total $ — $ — $ 13,064 $ 13,064 |
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | The following table provides a reconciliation between the beginning and ending balances of items measured at fair value on a recurring basis that used significant unobservable inputs (Level 3) (in thousands): Fair Value Measurements Using Significant Unobservable Inputs Balance at December 31, 2022 $ 13,064 Fair value adjustment 27,752 Balance at March 31, 2023 $ 40,816 |
GOODWILL AND INTANGIBLES (Table
GOODWILL AND INTANGIBLES (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill | The following table presents the changes in the Company’s goodwill balance (in thousands): Goodwill Balance at December 31, 2022 $ 161,527 Purchase price adjustment (85) Balance at March 31, 2023 $ 161,442 |
Schedule of Finite-Lived Intangible Assets | The following table presents the Company’s intangible asset balance by asset class as of March 31, 2023 (in thousands): Intangible Asset Cost Accumulated Amortization Net Book Value Amortization Method Useful Life Trade Names $ 900 $ (281) $ 619 Straight line 2 years Developed Technology 53,500 (7,672) 45,828 Straight line 4-10 years In-process R&D 1,177 — 1,177 Indefinite N/A Patents 33,900 (1,412) 32,488 Straight line 5-15 years Customer Relationships 24,300 (1,519) 22,781 Straight line 10 years Non-Competition Agreements 1,900 (238) 1,662 Straight line 5 years Other 1,926 (912) 1,014 Straight line 5 years Total $ 117,603 $ (12,034) $ 105,569 The following table presents the changes in the Company’s intangible asset balance (in thousands): Intangible Assets, net Balance at December 31, 2022 $ 105,620 Additions to intangible assets 4,485 Amortization expense (4,536) Balance at March 31, 2023 $ 105,569 |
Schedule of Indefinite-Lived Intangible Assets | The following table presents the Company’s intangible asset balance by asset class as of March 31, 2023 (in thousands): Intangible Asset Cost Accumulated Amortization Net Book Value Amortization Method Useful Life Trade Names $ 900 $ (281) $ 619 Straight line 2 years Developed Technology 53,500 (7,672) 45,828 Straight line 4-10 years In-process R&D 1,177 — 1,177 Indefinite N/A Patents 33,900 (1,412) 32,488 Straight line 5-15 years Customer Relationships 24,300 (1,519) 22,781 Straight line 10 years Non-Competition Agreements 1,900 (238) 1,662 Straight line 5 years Other 1,926 (912) 1,014 Straight line 5 years Total $ 117,603 $ (12,034) $ 105,569 |
LEASES (Tables)
LEASES (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Leases [Abstract] | |
Schedule of Lease, Cost | Information related to the Company right-of-use assets and related operating lease liabilities were as follows (in thousands): Three Months Ended March 31, 2023 2022 Cash paid for operating lease liabilities $ 454 $ 261 Operating lease cost $ 512 $ 263 Non-cash right-of-use assets obtained in exchange for new operating lease obligations $ 590 $ 1,391 Weighted-average remaining lease term 4.96 years 2.06 years Weight-average discount rate 4.25% - 7.75% 4.25 % |
Schedule of Right-of-Use Assets and Lease Liabilities | Right-of-use assets and lease liabilities consisted of the following (in thousands): March 31, 2023 December 31, 2022 Assets: Operating lease right-of-use assets $ 6,537 $ 6,381 Liabilities: Operating lease liabilities - current 1,477 1,305 Operating lease liabilities - noncurrent 5,248 5,263 Total lease liabilities $ 6,725 $ 6,568 |
Schedule of Lessee, Operating Lease, Liability, Maturity | Maturities of lease liabilities are as follows (in thousands): Remainder of fiscal year 2023 $ 1,422 Fiscal year 2024 1,532 Fiscal year 2025 1,239 Fiscal year 2026 1,183 Fiscal year 2027 1,218 Thereafter 1,125 $ 7,719 Less imputed interest 994 Total lease liabilities $ 6,725 |
SHARE BASED COMPENSATION (Table
SHARE BASED COMPENSATION (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount | The following table summarizes the stock-based compensation expense recognized for the three months ended March 31, 2023 and 2022: Three Months Ended March 31, 2023 2022 Research and development $ 7,177 $ 7,494 Selling, general and administrative 9,983 17,832 Total stock-based compensation expense $ 17,160 $ 25,326 |
Schedule of Stock Options, Valuation Assumptions | The valuation model utilized the following assumptions: Risk-free interest rates 1.47 % Expected volatility rates 58 % Expected dividend yield — Cost of equity (for derived service period) 9.96 % Weighted-average grant date fair value of options $ 8.13 Risk-free interest rates 2.82 % Expected volatility rates 63 % Expected dividend yield — Cost of equity (for derived service period) 14.64 % Weighted-average grant date fair value of options $ 2.51 |
Summary of Stock Option Outstanding | A summary of stock options outstanding, excluding LTIP Options as of March 31, 2023, and activity during the three months then ended, is presented below: Stock Options Shares Weighted- Weighted- Outstanding at December 31, 2022 6,775 $ 0.59 6.20 Granted — — — Exercised (512) 0.44 — Forfeited or expired (136) 1.06 — Cancelled — — — Outstanding at March 31, 2023 6,127 $ 0.61 6.20 Vested and Exercisable at March 31, 2023 5,015 $ 0.51 5.90 |
Summary of Restricted Stock Unit, Outstanding | A summary of RSUs outstanding as of March 31, 2023 , and activity during the three months then ended, is presented below: Shares Weighted-Average Grant Date Fair Value Per Share Outstanding at December 31, 2022 11,606 $ 5.93 Granted 5,392 6.15 Vested (1,707) 7.46 Forfeited (67) 6.62 Outstanding at March 31, 2023 15,224 $ 6.30 |
EARNOUT LIABILITY (Tables)
EARNOUT LIABILITY (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Warrants and Rights Note Disclosure [Abstract] | |
Schedule of Fair Value Of The Warrants | The valuation model utilized the following assumptions: March 31, 2023 December 31, 2022 Risk-free interest rate 3.75 % 4.13 % Equity volatility rate 63.00 % 65.00 % |
SIGNIFICANT CUSTOMERS AND CRE_2
SIGNIFICANT CUSTOMERS AND CREDIT CONCENTRATIONS (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Risks and Uncertainties [Abstract] | |
Schedule Of Concentration Risk | The following customers represented 10% or more of the Company’s net revenues for the three months ended March 31, 2023 and 2022: Three Months Ended March 31, Customer 2023 2022 Distributor A 35 % * Distributor B 19 * Distributor C 17 31 % Distributor D * 39 Distributor E * 13 *Total customer net revenues was less than 10% of total net revenues. The Company considers the domicile of its end customers, rather than the distributors it sells to directly, to be the basis for attributing revenues from external customers to individual countries. Revenues for the three months ended March 31, 2023 and 2022 were attributable to end customers in the following countries or regions: Three Months Ended March 31, Country 2023 2022 Europe* 28 % — China 57 58 % United States 11 33 Rest of Asia 4 9 All others — — Total 100 % 100 % *Impractical to disclose the revenue percentages by individual countries within Europe and therefore Europe is presented in total. Customer March 31, 2023 December 31, 2022 Distributor A 32 % 19 % Distributor B 19 25 Distributor C 11 * *Total customer accounts receivable was less than 10% of total net accounts receivable. |
NET INCOME (LOSS) PER SHARE (Ta
NET INCOME (LOSS) PER SHARE (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | A summary of the net income (loss) per share calculation is as follows (in thousands, except per share amounts): Three Months Ended March 31, Numerator - basic and diluted: 2023 2022 Net income (loss) attributable to controlling interests $ (61,847) $ 79,792 Denominator Weighted-average common shares - basic common stock 156,792 119,542 Weighted-average common shares - diluted common stock 156,792 131,149 Net income (loss) per share - basic common stock $ (0.39) $ 0.67 Net income (loss) per share - diluted common stock $ (0.39) $ 0.61 Denominator Weighted-average common shares - basic common stock 156,792 119,542 Stock options and other dilutive awards — 11,607 Weighted-average common shares - diluted common stock 156,792 131,149 Shares excluded from diluted weighted-average shares: 1 Earnout shares (potentially issuable common shares) 10,000 10,000 Unvested restricted stock units and restricted stock awards 376 4,979 Stock options potentially exercisable for common shares 9,750 6,500 Shares excluded from diluted weighted average shares 20,126 21,479 (1) The Company’s potentially dilutive securities, which include unexercised stock options, unvested shares, preferred shares, earnout shares, and warrants for common and preferred shares, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share for the three months ended March 31, 2023. |
BUSINESS COMBINATIONS (Tables)
BUSINESS COMBINATIONS (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | The following tables summarize the purchase consideration and the purchase price allocation to estimated fair values of the identifiable assets acquired and liabilities assumed (in thousands): Merger Consideration Fair Value Cash consideration at closing $ 97,116 Equity consideration at closing 146,314 Contingent earn-out 600 Total $ 244,030 Estimate of purchase price allocation Cash and cash equivalents $ 951 Accounts receivable 823 Inventory 1,539 Fixed assets 226 Other assets 5 Intangible assets 110,100 Goodwill 157,699 Total assets acquired $ 271,343 Liabilities assumed: Interest bearing debt 16 Other current liabilities 2,749 Deferred tax liabilities 24,548 Total liabilities acquired 27,313 Estimated fair value of net assets acquired $ 244,030 |
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination | The fair values of the identifiable intangible assets acquired at the date of Acquisition are as follows (in thousands): Intangible Asset Fair Value Amortization Method Useful Life Trade Names $ 900 Straight line 2 years Developed Technology 49,100 Straight line 4 years Patents 33,900 Straight line 15 years Customer Relationships 24,300 Straight line 10 years Non-Competition Agreements 1,900 Straight line 5 years Total Intangibles $ 110,100 |
Business Acquisition, Pro Forma Information | The following unaudited pro forma financial information presented in the table below is provided for illustrative purposes only and is based on the historical financial statements of the Company and presents the Company’s results as if the business combination had occurred as of January 1, 2022 (in thousands): UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2022 Revenue $ 11,476 Net income $ 79,741 Basic net income per share $ 0.55 Diluted net income per share $ 0.51 |
ORGANIZATION AND BASIS OF PRE_2
ORGANIZATION AND BASIS OF PRESENTATION (Details) - USD ($) $ in Thousands | 1 Months Ended | ||||
Jan. 19, 2023 | Aug. 15, 2022 | Jun. 10, 2022 | Jan. 31, 2023 | Aug. 31, 2022 | |
IC Joint Venture | |||||
Business Acquisition [Line Items] | |||||
Purchase price of minority interest | $ 22,400 | $ 22,400 | |||
Goodwill | |||||
Business Acquisition [Line Items] | |||||
Total | $ 1,900 | ||||
GeneSiC | |||||
Business Acquisition [Line Items] | |||||
Total | $ 244,030 | $ 246,200 |
INVENTORY (Details)
INVENTORY (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 3,551 | $ 4,314 |
Work-in-process | 11,609 | 9,166 |
Finished goods | 3,713 | 5,581 |
Total | $ 18,873 | $ 19,061 |
PROPERTY AND EQUIPMENT, NET (De
PROPERTY AND EQUIPMENT, NET (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | $ 10,382 | $ 9,520 | |
Accumulated depreciation | (3,542) | (2,988) | |
Total | 6,840 | 6,532 | |
Depreciation | 506 | $ 125 | |
Furniture and fixtures | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | $ 202 | 215 | |
Furniture and fixtures | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Estimated useful life | 3 years | ||
Furniture and fixtures | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Estimated useful life | 7 years | ||
Computers and other equipment | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | $ 8,064 | 7,251 | |
Computers and other equipment | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Estimated useful life | 2 years | ||
Computers and other equipment | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Estimated useful life | 5 years | ||
Leasehold improvements | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | $ 2,045 | 2,054 | |
Leasehold improvements | Minimum | |||
Property, Plant and Equipment [Line Items] | |||
Estimated useful life | 2 years | ||
Leasehold improvements | Maximum | |||
Property, Plant and Equipment [Line Items] | |||
Estimated useful life | 5 years | ||
Construction in Progress | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, gross | $ 71 | $ 0 |
FAIR VALUE OF FINANCIAL ASSET_3
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES - Narrative (Details) - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
Level 1 | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Cash equivalents classified as Level 1 instruments | $ 0 | $ 0 |
FAIR VALUE OF FINANCIAL ASSET_4
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES - Fair Value Hierarchy (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | Oct. 19, 2021 |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Earnouts, fair value | $ 40,816 | $ 13,064 | $ 96,100 |
Fair Value, Recurring | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Total | 40,816 | 13,064 | |
Fair Value, Recurring | Earnout liability | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Earnouts, fair value | 40,816 | 13,064 | |
Fair Value, Recurring | Level 1 | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Total | 0 | 0 | |
Fair Value, Recurring | Level 1 | Earnout liability | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Earnouts, fair value | 0 | 0 | |
Fair Value, Recurring | Level 2 | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Total | 0 | 0 | |
Fair Value, Recurring | Level 2 | Earnout liability | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Earnouts, fair value | 0 | 0 | |
Fair Value, Recurring | Level 3 | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Total | 40,816 | 13,064 | |
Fair Value, Recurring | Level 3 | Earnout liability | |||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |||
Earnouts, fair value | $ 40,816 | $ 13,064 |
FAIR VALUE OF FINANCIAL ASSET_5
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES - Level 3 Reconciliation (Details) - Earnout liability - Level 3 - Fair Value, Recurring $ in Thousands | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Balance at December 31, 2022 | $ 13,064 |
Fair value adjustment | 27,752 |
Balance at March 31, 2023 | $ 40,816 |
GOODWILL AND INTANGIBLES - Good
GOODWILL AND INTANGIBLES - Goodwill Rollforward (Details) $ in Thousands | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Goodwill [Roll Forward] | |
Goodwill, beginning balance | $ 161,527 |
Goodwill, ending balance | 161,442 |
Goodwill | |
Goodwill [Roll Forward] | |
Goodwill, beginning balance | 161,527 |
Purchase price adjustment | (85) |
Goodwill, ending balance | $ 161,442 |
GOODWILL AND INTANGIBLES - Inta
GOODWILL AND INTANGIBLES - Intangible Assets (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Finite-Lived Intangible Assets [Line Items] | |||
Accumulated Amortization | $ (12,034,000) | ||
Total, Cost | 117,603,000 | ||
INTANGIBLE ASSETS, net | 105,569,000 | $ 105,620,000 | |
Amortization of intangible assets | 4,499,000 | $ 88,000 | |
Goodwill, impairment loss | 0 | $ 0 | |
In-process R&D | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost and Net Book Value | 1,177,000 | ||
Trade Names | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost | 900,000 | ||
Accumulated Amortization | (281,000) | ||
Net Book Value | $ 619,000 | ||
Useful Life | 2 years | ||
Developed Technology | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost | $ 53,500,000 | ||
Accumulated Amortization | (7,672,000) | ||
Net Book Value | $ 45,828,000 | ||
Developed Technology | Minimum | |||
Finite-Lived Intangible Assets [Line Items] | |||
Useful Life | 4 years | ||
Developed Technology | Maximum | |||
Finite-Lived Intangible Assets [Line Items] | |||
Useful Life | 10 years | ||
Patents | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost | $ 33,900,000 | ||
Accumulated Amortization | (1,412,000) | ||
Net Book Value | $ 32,488,000 | ||
Patents | Minimum | |||
Finite-Lived Intangible Assets [Line Items] | |||
Useful Life | 5 years | ||
Patents | Maximum | |||
Finite-Lived Intangible Assets [Line Items] | |||
Useful Life | 15 years | ||
Customer Relationships | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost | $ 24,300,000 | ||
Accumulated Amortization | (1,519,000) | ||
Net Book Value | $ 22,781,000 | ||
Useful Life | 10 years | ||
Non-Competition Agreements | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost | $ 1,900,000 | ||
Accumulated Amortization | (238,000) | ||
Net Book Value | $ 1,662,000 | ||
Useful Life | 5 years | ||
Other | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost | $ 1,926,000 | ||
Accumulated Amortization | (912,000) | ||
Net Book Value | $ 1,014,000 | ||
Useful Life | 5 years |
GOODWILL AND INTANGIBLES - Sche
GOODWILL AND INTANGIBLES - Schedule Of Intangible Asset (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Finite-Lived Intangible Assets [Roll Forward] | ||
Beginning Balance | $ 105,620 | |
Additions to intangible assets | 4,485 | |
Amortization expense | (4,536) | $ (88) |
Ending Balance | $ 105,569 |
DEBT OBLIGATIONS (Details)
DEBT OBLIGATIONS (Details) | Apr. 29, 2020 USD ($) |
Secured Debt | Term Loan | |
Debt Instrument [Line Items] | |
Maximum available amount | $ 8,000,000 |
LEASES - Narrative (Details)
LEASES - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | |||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | Jan. 01, 2022 | |
Lessee, Lease, Description [Line Items] | ||||
Operating lease right-of-use assets | $ 6,537 | $ 6,381 | $ 1,600 | |
Operating lease liability | 6,725 | $ 6,568 | $ 1,700 | |
Right-of-use assets in exchange for lease obligations | 590 | $ 1,391 | ||
Rent expense, including short-term lease cost | $ 500 | $ 400 | ||
Minimum | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease, term | 6 months | |||
Maximum | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease, term | 5 years 8 months 12 days |
LEASES - Operating Lease Liabil
LEASES - Operating Lease Liabilities (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Lessee, Lease, Description [Line Items] | ||
Cash paid for operating lease liabilities | $ 454 | $ 261 |
Operating lease cost | 512 | 263 |
Non-cash right-of-use assets obtained in exchange for new operating lease obligations | $ 590 | $ 1,391 |
Weighted-average remaining lease term | 4 years 11 months 15 days | 2 years 21 days |
Weight-average discount rate | 4.25% | |
Minimum | ||
Lessee, Lease, Description [Line Items] | ||
Weight-average discount rate | 4.25% | |
Maximum | ||
Lessee, Lease, Description [Line Items] | ||
Weight-average discount rate | 7.75% |
LEASES - Right-of-Use Assets an
LEASES - Right-of-Use Assets and Lease Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | Jan. 01, 2022 |
Leases [Abstract] | |||
Operating lease right-of-use assets | $ 6,537 | $ 6,381 | $ 1,600 |
Operating lease liabilities - current | 1,477 | 1,305 | |
Operating lease liabilities - noncurrent | 5,248 | 5,263 | |
Total lease liabilities | $ 6,725 | $ 6,568 | $ 1,700 |
LEASES - Maturities Of Lease Li
LEASES - Maturities Of Lease Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | Jan. 01, 2022 |
Leases [Abstract] | |||
Remainder of fiscal year 2023 | $ 1,422 | ||
Fiscal year 2024 | 1,532 | ||
Fiscal year 2025 | 1,239 | ||
Fiscal year 2026 | 1,183 | ||
Fiscal year 2027 | 1,218 | ||
Thereafter | 1,125 | ||
Operating lease, liability, to be paid | 7,719 | ||
Less imputed interest | 994 | ||
Total lease liabilities | $ 6,725 | $ 6,568 | $ 1,700 |
SHARE BASED COMPENSATION - Narr
SHARE BASED COMPENSATION - Narrative (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | ||||||||
Jan. 19, 2023 USD ($) shares | Aug. 15, 2022 hurdle $ / shares shares | Dec. 29, 2021 hurdle $ / shares shares | Oct. 19, 2021 shares | Aug. 25, 2021 installment shares | Aug. 05, 2020 shares | Mar. 31, 2023 USD ($) $ / shares shares | Mar. 31, 2022 USD ($) | Dec. 31, 2022 USD ($) | Aug. 17, 2021 shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Exchange ratio | 1.0944 | |||||||||
Requisite service period | 4 years | |||||||||
Total stock-based compensation expense | $ | $ 17,160 | $ 25,326 | ||||||||
Options granted (in shares) | shares | 0 | |||||||||
Weighted average remaining contractual term (in years) | 6 years 2 months 12 days | 6 years 2 months 12 days | ||||||||
Former Employees | IC Joint Venture | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Granted (in shares) | shares | 841,729 | |||||||||
Aggregated grant date fair value | $ | $ 4,500 | |||||||||
Employee Stock | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total stock-based compensation expense | $ | $ 100 | 100 | ||||||||
Unrecognized compensation cost | $ | $ 500 | |||||||||
Unrecognized compensation expense, period of recognition | 1 year 2 months 12 days | |||||||||
LTIP Options | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total stock-based compensation expense | $ | $ 2,500 | 1,400 | ||||||||
Exercise price (in dollars per share) | $ / shares | $ 2.51 | $ 8.13 | ||||||||
LTIP Options | December 29, 2021 | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total stock-based compensation expense | $ | 2,200 | 1,400 | ||||||||
Unrecognized compensation cost | $ | $ 51,600 | |||||||||
Unrecognized compensation expense, period of recognition | 3 years 2 months 12 days | |||||||||
LTIP Options | August 15, 2022 | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total stock-based compensation expense | $ | $ 300 | |||||||||
Unrecognized compensation expense, period of recognition | 3 years 9 months 18 days | |||||||||
Unrecognized compensation cost | $ | $ 8,700 | |||||||||
Restricted Stock Units | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total stock-based compensation expense | $ | $ 7,100 | 16,200 | ||||||||
Unrecognized compensation expense, period of recognition | 2 years 9 months 18 days | |||||||||
Granted (in shares) | shares | 4,135,000 | 5,392,000 | ||||||||
Right to receive (in shares) | shares | 1 | |||||||||
Unrecognized compensation expense | $ | $ 90,200 | |||||||||
Fair value (in dollars per share) | $ / shares | $ 6.15 | |||||||||
Restricted Stock Units | Share-based Payment Arrangement, Tranche One | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Award vesting period | 3 years | |||||||||
Awards subject to vesting (in shares) | shares | 3,500,000 | |||||||||
Installments, vesting | installment | 3 | |||||||||
Restricted Stock Units | Share-based Payment Arrangement, Tranche Two | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Award vesting period | 6 months | |||||||||
Awards subject to vesting (in shares) | shares | 500,000 | |||||||||
Restricted Stock Units | Share-based Payment Arrangement, Tranche Three | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Awards subject to vesting (in shares) | shares | 52,500 | |||||||||
Restricted Stock Units | Share-based Payment Arrangement, Tranche Four | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Award vesting period | 3 years | |||||||||
Awards subject to vesting (in shares) | shares | 82,500 | |||||||||
Earnout shares (potentially issuable common shares) | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total stock-based compensation expense | $ | $ 300 | $ 6,300 | ||||||||
Aggregated grant date fair value | $ | $ 19,100 | |||||||||
Fair value (in dollars per share) | $ / shares | $ 11.52 | |||||||||
2020 Equity Incentive Plan | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Authorized shares (in shares) | shares | 18,899,285 | |||||||||
2020 Equity Incentive Plan | Stock options potentially exercisable for common shares | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Award vesting period | 48 months | |||||||||
Options expiration period | 10 years | |||||||||
Options issued (in shares) | shares | 11,276,706 | |||||||||
2020 Equity Incentive Plan | Stock options potentially exercisable for common shares | Share-based Payment Arrangement, Tranche One | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Vesting ratio | 0.25 | |||||||||
2020 Equity Incentive Plan | Stock options potentially exercisable for common shares | Share-based Payment Arrangement, Tranche Two | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Vesting ratio | 0.02 | |||||||||
2020 Equity Incentive Plan | Restricted Stock | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Options issued (in shares) | shares | 4,525,344 | |||||||||
2021 Equity Incentive Plan | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Authorized shares (in shares) | shares | 16,334,527 | |||||||||
Options issued (in shares) | shares | 9,750,000 | |||||||||
Shares of common stock subject to awards forfeited, expire or lapse (in shares) | shares | 15,802,050 | |||||||||
Shares of common stock outstanding, percentage | 4% | |||||||||
2021 Equity Incentive Plan | LTIP Options | Management | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Requisite service period | 7 years | 7 years | ||||||||
Options granted (in shares) | shares | 3,250,000 | 6,500,000 | ||||||||
Number of price hurdles | hurdle | 10 | 10 | ||||||||
Exercise price (in dollars per share) | $ / shares | $ 10 | $ 15.51 | ||||||||
Exercise price (in dollars per share) | $ / shares | $ 2.51 | |||||||||
Weighted average remaining contractual term (in years) | 9 years 4 months 24 days | 8 years 9 months 18 days | ||||||||
2021 Equity Incentive Plan | LTIP Options | Management | Black Scholes and Monte Carlo Model Member | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Exercise price (in dollars per share) | $ / shares | 8.13 | |||||||||
2021 Equity Incentive Plan | LTIP Options | Minimum | Management | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Price hurdles (in dollars per share) | $ / shares | $ 15 | 15 | ||||||||
2021 Equity Incentive Plan | LTIP Options | Maximum | Management | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Price hurdles (in dollars per share) | $ / shares | $ 60 | $ 60 | ||||||||
Annual Bonus Plan, 2023 | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Accrued bonus liabilities | $ | $ 2,300 | |||||||||
Annual Bonus Plan, 2022 | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Accrued bonus liabilities | $ | $ 100 | $ 2,800 |
SHARE BASED COMPENSATION - Stoc
SHARE BASED COMPENSATION - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $ 17,160 | $ 25,326 |
Research and development | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | 7,177 | 7,494 |
Selling, general and administrative | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $ 9,983 | $ 17,832 |
SHARE BASED COMPENSATION - Sche
SHARE BASED COMPENSATION - Schedule Of Valuation Assumption (Details) - LTIP Options - $ / shares | Aug. 15, 2022 | Dec. 29, 2021 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Risk-free interest rates | 2.82% | 1.47% |
Expected volatility rates | 63% | 58% |
Expected dividend yield | 0% | 0% |
Expected term (in years) | 14.64% | 9.96% |
Weighted average fair value, unvested options granted (in dollars per share) | $ 2.51 | $ 8.13 |
SHARE BASED COMPENSATION - Summ
SHARE BASED COMPENSATION - Summary Of Stock Option Outstanding (Details) - $ / shares shares in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] | ||
Balance at the beginning (in shares) | 6,775 | |
Options granted (in shares) | 0 | |
Options exercised (in shares) | (512) | |
Options forfeited or expired (in shares) | (136) | |
Options cancelled (in shares) | 0 | |
Balance at the end (in shares) | 6,127 | 6,775 |
Vested and exercisable at the end ( in shares) | 5,015 | |
Weighted- Average Exercise Price | ||
Weighted average exercise price, balance at the beginning (in dollars per share) | $ 0.59 | |
Weighted average exercise price, granted (in dollars per share) | 0 | |
Weighted average exercise price, exercised (in dollars per share) | 0.44 | |
Weighted average exercise price, forfeited or expired (in dollars per share) | 1.06 | |
Weighted average exercise price, cancelled (in dollars per share) | 0 | |
Weighted average exercise price, balance at the end (in dollars per share) | 0.61 | $ 0.59 |
Weighted average exercise price, vested and exercisable at the end (in dollars per share) | $ 0.51 | |
Weighted- Average Remaining Contractual Term (In years) | ||
Weighted average remaining contractual term (in years) | 6 years 2 months 12 days | 6 years 2 months 12 days |
Weighted average remaining contractual term, vested and exercisable options (in years) | 5 years 10 months 24 days |
SHARE BASED COMPENSATION - Su_2
SHARE BASED COMPENSATION - Summary Of Restricted Stock (Details) - Unvested restricted stock units and restricted stock awards - $ / shares | 3 Months Ended | |
Aug. 25, 2021 | Mar. 31, 2023 | |
Shares (In thousands) | ||
Outstanding balance at the beginning (in shares) | 11,606,000 | |
Granted (in shares) | 4,135,000 | 5,392,000 |
Vested (in shares) | (1,707,000) | |
Forfeited (in shares) | (67,000) | |
Outstanding balance at the end (in shares) | 15,224,000 | |
Weighted-Average Grant Date Fair Value Per Share | ||
Weighted average grant date fair value, outstanding balance at the beginning ( in dollars per share) | $ 5.93 | |
Weighted average grant date fair value, granted (in dollars per share) | 6.15 | |
Weighted average grant date fair value, vested (in dollars per share) | 7.46 | |
Weighted average grant date fair value, forfeited (in dollars per share) | 6.62 | |
Weighted average grant date fair value, outstanding balance at the end ( in dollars per share) | $ 6.30 |
WARRANT LIABILITY (Details)
WARRANT LIABILITY (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | ||||||
Feb. 04, 2022 $ / shares shares | Oct. 19, 2021 day $ / shares shares | Mar. 31, 2023 USD ($) shares | Mar. 31, 2022 USD ($) | Feb. 22, 2022 day $ / shares | Feb. 03, 2022 USD ($) | Dec. 02, 2020 $ / shares | |
Class of Warrant or Right [Line Items] | |||||||
Warrants outstanding (in shares) | 0 | ||||||
Initial fair value | $ | $ 81,400 | ||||||
Gain from change in fair value of warrants | $ | $ 0 | $ 51,763 | |||||
The Warrants | |||||||
Class of Warrant or Right [Line Items] | |||||||
Warrants outstanding (in shares) | 377,187 | 13,100,000 | |||||
Warrants exercised (in shares) | 12,722,773 | ||||||
Warrant exercisable after IPO, period | 12 months | ||||||
Warrant exercise period | 5 years | ||||||
Warrants exercised, cash basis (in shares) | 17,785 | ||||||
Warrants exercised, cashless basis (in shares) | 12,704,988 | ||||||
Redemption, minimum price (in dollars per share) | $ / shares | $ 38 | ||||||
The Warrants | Common Class A | |||||||
Class of Warrant or Right [Line Items] | |||||||
Warrants, exercisable price (in dollars per share) | $ / shares | $ 11.50 | $ 10.33 | $ 0.10 | ||||
Warrants exercised (in shares) | 3,333,650 | ||||||
Volume weighted average price trading days | day | 10 | 10 | |||||
Redemption conversion ratio | 0.261 | ||||||
Warrants exercised, cash basis (in shares) | 17,785 | ||||||
Warrants exercised, cashless basis (in shares) | 3,315,865 | ||||||
Public Warrants | Redemption Option One | |||||||
Class of Warrant or Right [Line Items] | |||||||
Written notice of redemption, period | 3 days | ||||||
Public Warrants | Redemption Option Two | |||||||
Class of Warrant or Right [Line Items] | |||||||
Written notice of redemption, period | 3 days | ||||||
Public Warrants | Redemption Option Three | |||||||
Class of Warrant or Right [Line Items] | |||||||
Written notice of redemption, period | 3 days | ||||||
Public Warrants | LOKB | |||||||
Class of Warrant or Right [Line Items] | |||||||
Warrants outstanding (in shares) | 8,433,333 | ||||||
Public Warrants | Common Class A | |||||||
Class of Warrant or Right [Line Items] | |||||||
Warrants outstanding (in shares) | 8,433,333 | ||||||
Number of shares exercisable under warrants (in shares) | 1 | ||||||
Public Warrants | Common Class A | Redemption Option One | |||||||
Class of Warrant or Right [Line Items] | |||||||
Warrants, exercisable price (in dollars per share) | $ / shares | $ 0.01 | ||||||
Written notice of redemption, period | 30 days | ||||||
Redemption, threshold trading days | day | 20 | ||||||
Redemption, threshold consecutive trading days | day | 30 | ||||||
Public Warrants | Common Class A | Redemption Option One | Minimum | |||||||
Class of Warrant or Right [Line Items] | |||||||
Reported closing price of Common Stock (in dollar per share) | $ / shares | $ 18 | ||||||
Public Warrants | Common Class A | Redemption Option Two | |||||||
Class of Warrant or Right [Line Items] | |||||||
Warrants, exercisable price (in dollars per share) | $ / shares | $ 0.10 | ||||||
Written notice of redemption, period | 30 days | ||||||
Redemption, threshold trading days | day | 20 | ||||||
Redemption, threshold consecutive trading days | day | 30 | ||||||
Public Warrants | Common Class A | Redemption Option Two | Minimum | |||||||
Class of Warrant or Right [Line Items] | |||||||
Reported closing price of Common Stock (in dollar per share) | $ / shares | $ 10 | ||||||
Public Warrants | Common Class A | Redemption Option Three | |||||||
Class of Warrant or Right [Line Items] | |||||||
Warrants, exercisable price (in dollars per share) | $ / shares | $ 0.10 | ||||||
Redemption, threshold trading days | day | 20 | ||||||
Redemption, threshold consecutive trading days | day | 30 | ||||||
Public Warrants | Common Class A | Redemption Option Three | Minimum | |||||||
Class of Warrant or Right [Line Items] | |||||||
Reported closing price of Common Stock (in dollar per share) | $ / shares | $ 18 | ||||||
Private Placement Warrants | |||||||
Class of Warrant or Right [Line Items] | |||||||
Warrants exercised (in shares) | 4,666,667 | ||||||
Private Placement Warrants | Common Class A | |||||||
Class of Warrant or Right [Line Items] | |||||||
Number of shares exercisable under warrants (in shares) | 1 | ||||||
Warrants, exercisable price (in dollars per share) | $ / shares | $ 11.50 | ||||||
Private Placement Warrants | Class A Ordinary Shares | |||||||
Class of Warrant or Right [Line Items] | |||||||
Number of shares exercisable under warrants (in shares) | 1 | ||||||
Warrants, exercisable price (in dollars per share) | $ / shares | $ 11.50 |
EARNOUT LIABILITY - Narrative (
EARNOUT LIABILITY - Narrative (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | ||||
Oct. 19, 2021 USD ($) day $ / shares shares | Mar. 31, 2023 USD ($) | Mar. 31, 2022 USD ($) | Dec. 31, 2022 USD ($) | Aug. 15, 2022 USD ($) | |
Class of Warrant or Right [Line Items] | |||||
Earnouts, fair value | $ 96,100 | $ 40,816 | $ 13,064 | ||
(Gain) loss from change in fair value of earnout liability | 27,752 | $ (63,406) | |||
Estimate of Fair Value Measurement | |||||
Class of Warrant or Right [Line Items] | |||||
Earnouts, fair value | 40,400 | $ 12,500 | |||
(Gain) loss from change in fair value of earnout liability | 27,900 | ||||
GeneSiC | |||||
Class of Warrant or Right [Line Items] | |||||
Earnouts, fair value | 400 | ||||
Possible earn-out payments | $ 25,000 | $ 25,000 | |||
GeneSiC | Estimate of Fair Value Measurement | |||||
Class of Warrant or Right [Line Items] | |||||
Possible earn-out payments | $ 600 | ||||
Risk-free interest rate | GeneSiC | |||||
Class of Warrant or Right [Line Items] | |||||
Business combination, liability, measurement input | 0.031 | ||||
Measurement Input, Option Volatility | GeneSiC | |||||
Class of Warrant or Right [Line Items] | |||||
Business combination, liability, measurement input | 0.999 | ||||
Earnout shares (potentially issuable common shares) | |||||
Class of Warrant or Right [Line Items] | |||||
Earnout, additional shares (in shares) | shares | 3,333,333 | ||||
Earnout shares (potentially issuable common shares) | Common Class A | |||||
Class of Warrant or Right [Line Items] | |||||
Earnout, additional shares (in shares) | shares | 10,000,000 | ||||
Trading days | day | 20 | ||||
Consecutive trading days | day | 30 | ||||
Earnout shares (potentially issuable common shares) | Common Class A | Triggering Event 1 | |||||
Class of Warrant or Right [Line Items] | |||||
Stock price trigger (in dollars per share) | $ / shares | $ 12.50 | ||||
Earnout shares (potentially issuable common shares) | Common Class A | Triggering Event 2 | |||||
Class of Warrant or Right [Line Items] | |||||
Stock price trigger (in dollars per share) | $ / shares | 17 | ||||
Earnout shares (potentially issuable common shares) | Common Class A | Triggering Event 3 | |||||
Class of Warrant or Right [Line Items] | |||||
Stock price trigger (in dollars per share) | $ / shares | $ 20 |
EARNOUT LIABILITY - Valuation M
EARNOUT LIABILITY - Valuation Model and Assumptions (Details) - Earnout shares (potentially issuable common shares) | Mar. 31, 2023 | Dec. 31, 2022 |
Risk-free interest rate | ||
Class of Warrant or Right [Line Items] | ||
Earnout liability, measurement input | 0.0375 | 0.0413 |
Equity volatility rate | ||
Class of Warrant or Right [Line Items] | ||
Earnout liability, measurement input | 0.6300 | 0.6500 |
SIGNIFICANT CUSTOMERS AND CRE_3
SIGNIFICANT CUSTOMERS AND CREDIT CONCENTRATIONS (Details) | 3 Months Ended | 6 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | Jun. 30, 2022 | |
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 100% | 100% | |
Europe | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 28% | 0% | |
China | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 57% | 58% | |
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 11% | 33% | |
Rest of Asia | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 4% | 9% | |
All others | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 0% | 0% | |
Distributor A | Revenue from Contract with Customer Benchmark | Customer Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 35% | ||
Distributor A | Accounts Receivable | Customer Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 32% | 19% | |
Distributor B | Revenue from Contract with Customer Benchmark | Customer Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 19% | ||
Distributor B | Accounts Receivable | Customer Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 19% | 25% | |
Distributor C | Revenue from Contract with Customer Benchmark | Customer Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 17% | 31% | |
Distributor C | Accounts Receivable | Customer Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 11% | ||
Distributor D | Revenue from Contract with Customer Benchmark | Customer Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 39% | ||
Distributor E | Revenue from Contract with Customer Benchmark | Customer Concentration Risk | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 13% |
NET INCOME (LOSS) PER SHARE (De
NET INCOME (LOSS) PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Numerator - basic and diluted: | ||
Net income (loss) | $ (61,847) | $ 79,792 |
Denominator | ||
Weighted-average common shares - basic common stock (in shares) | 156,792 | 119,542 |
Weighted-average common shares - diluted common stock (in shares) | 156,792 | 131,149 |
Net income (loss) per share - basic common stock (in dollars per share) | $ (0.39) | $ 0.67 |
Net income (loss) per share - diluted common stock (in dollars per share) | $ (0.39) | $ 0.61 |
Stock options and other dilutive awards (in shares) | 0 | 11,607 |
Weighted-average common shares - diluted common stock (in shares) | 156,792 | 131,149 |
Shares excluded from diluted weighted-average shares: | ||
Antidilutive securities (in shares) | 20,126 | 21,479 |
Earnout shares (potentially issuable common shares) | ||
Shares excluded from diluted weighted-average shares: | ||
Antidilutive securities (in shares) | 10,000 | 10,000 |
Unvested restricted stock units and restricted stock awards | ||
Shares excluded from diluted weighted-average shares: | ||
Antidilutive securities (in shares) | 376 | 4,979 |
Stock options potentially exercisable for common shares | ||
Shares excluded from diluted weighted-average shares: | ||
Antidilutive securities (in shares) | 9,750 | 6,500 |
PROVISION FOR INCOME TAXES (Det
PROVISION FOR INCOME TAXES (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | ||
Effective tax rate | (0.03%) | 0% |
Unrecognized tax benefits | $ 0 | $ 0 |
Unrecognized tax benefits, income tax penalties and interest expense | $ 0 | $ 0 |
COMMITMENTS and CONTINGENCIES (
COMMITMENTS and CONTINGENCIES (Details) $ in Millions | Mar. 31, 2023 USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
Severance payments, aggregate amount to be paid | $ 2.1 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||
Jan. 19, 2023 | Jan. 31, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2022 | |
IC Joint Venture | ||||||
Related Party Transaction [Line Items] | ||||||
Purchase price of minority interest | $ 22,400 | $ 22,400 | ||||
Affiliated Entity | Note Receivable With An Employee | ||||||
Related Party Transaction [Line Items] | ||||||
Loss on extinguishment of debt | $ 100 | |||||
Related parties, proceeds | $ 100 | |||||
Affiliated Entity | Note Receivable With An Employee | Minimum | ||||||
Related Party Transaction [Line Items] | ||||||
Interest rate | 1% | |||||
Affiliated Entity | Note Receivable With An Employee | Maximum | ||||||
Related Party Transaction [Line Items] | ||||||
Interest rate | 2.76% | |||||
Affiliated Entity | Joint Venture Investment | ||||||
Related Party Transaction [Line Items] | ||||||
Investment in preferred interest | $ 1,000 | $ 1,500 | ||||
Payment to joint venture partner | 100 | $ 1,000 | ||||
Rent obligation | 43 | |||||
Corporate Joint Venture | Joint Venture Investment | ||||||
Related Party Transaction [Line Items] | ||||||
Related party revenues recognized | $ 0 | $ 600 |
BUSINESS COMBINATIONS - Narrati
BUSINESS COMBINATIONS - Narrative (Details) shares in Thousands, $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||||
Aug. 15, 2022 USD ($) | Jun. 10, 2022 USD ($) shares | Aug. 25, 2021 | Aug. 31, 2022 USD ($) | Mar. 31, 2023 USD ($) | Sep. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) | Jun. 30, 2022 USD ($) | |
Business Acquisition [Line Items] | ||||||||
Goodwill | $ 161,442 | $ 161,527 | ||||||
Fair Value | 4,485 | |||||||
Unvested restricted stock units and restricted stock awards | Share-based Payment Arrangement, Tranche One | ||||||||
Business Acquisition [Line Items] | ||||||||
Award vesting period | 3 years | |||||||
Unvested restricted stock units and restricted stock awards | Share-based Payment Arrangement, Tranche Two | ||||||||
Business Acquisition [Line Items] | ||||||||
Award vesting period | 6 months | |||||||
Goodwill | ||||||||
Business Acquisition [Line Items] | ||||||||
Total | $ 1,900 | |||||||
Goodwill | 161,442 | 161,527 | $ 1,200 | |||||
Fair Value | $ 1,200 | |||||||
Goodwill | Developed Technology | Measurement Input, Discount Rate | Level 3 | Valuation, Income Approach | ||||||||
Business Acquisition [Line Items] | ||||||||
Measurement input of intangible assets acquired | 0.18 | |||||||
Goodwill | Unvested restricted stock units and restricted stock awards | Share-based Payment Arrangement, Tranche One | ||||||||
Business Acquisition [Line Items] | ||||||||
Options issued (in shares) | shares | 113,000 | |||||||
Award vesting period | 4 years | |||||||
Goodwill | Unvested restricted stock units and restricted stock awards | Share-based Payment Arrangement, Tranche Two | ||||||||
Business Acquisition [Line Items] | ||||||||
Options issued (in shares) | shares | 151,000 | |||||||
Award vesting period | 3 years | |||||||
GeneSiC | ||||||||
Business Acquisition [Line Items] | ||||||||
Total | $ 244,030 | $ 246,200 | ||||||
Goodwill | 157,699 | |||||||
Fair Value | $ 110,100 | |||||||
Percentage of voting interests acquired | 100% | |||||||
Equity consideration at closing | $ 146,314 | |||||||
Purchase price, cash | 97,116 | |||||||
Possible earn-out payments | 25,000 | $ 25,000 | ||||||
Transaction costs | $ 5,900 | |||||||
GeneSiC | Developed Technology | ||||||||
Business Acquisition [Line Items] | ||||||||
Fair Value | $ 49,100 | |||||||
GeneSiC | Developed Technology | Measurement Input, Discount Rate | Level 3 | Valuation, Income Approach | ||||||||
Business Acquisition [Line Items] | ||||||||
Measurement input of intangible assets acquired | 0.15 | |||||||
GeneSiC | Customer Relationships | ||||||||
Business Acquisition [Line Items] | ||||||||
Fair Value | $ 24,300 | |||||||
GeneSiC | Customer Relationships | Measurement Input, Discount Rate | Level 3 | Valuation, Income Approach | ||||||||
Business Acquisition [Line Items] | ||||||||
Measurement input of intangible assets acquired | 0.16 | |||||||
GeneSiC | Trademarks and Trade Names | Measurement Input, Discount Rate | Level 3 | Valuation, Income Approach | ||||||||
Business Acquisition [Line Items] | ||||||||
Measurement input of intangible assets acquired | 0.01 | |||||||
GeneSiC | Patents | Measurement Input, Discount Rate | Level 3 | Valuation, Income Approach | ||||||||
Business Acquisition [Line Items] | ||||||||
Measurement input of intangible assets acquired | 5 | |||||||
GeneSiC | Non-Competition Agreements | ||||||||
Business Acquisition [Line Items] | ||||||||
Fair Value | $ 1,900 | |||||||
GeneSiC | Non-Competition Agreements | Measurement Input, Discount Rate | Level 3 | Valuation, Income Approach | ||||||||
Business Acquisition [Line Items] | ||||||||
Measurement input of intangible assets acquired | 0.16 | |||||||
GeneSiC | Estimate of Fair Value Measurement | ||||||||
Business Acquisition [Line Items] | ||||||||
Possible earn-out payments | $ 600 |
BUSINESS COMBINATIONS - Recogni
BUSINESS COMBINATIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands | 1 Months Ended | |||
Aug. 15, 2022 | Aug. 31, 2022 | Mar. 31, 2023 | Dec. 31, 2022 | |
Estimate of purchase price allocation | ||||
Goodwill | $ 161,442 | $ 161,527 | ||
GeneSiC | ||||
Business Acquisition [Line Items] | ||||
Cash consideration at closing | $ 97,116 | |||
Equity consideration at closing | 146,314 | |||
Contingent earn-out | 600 | |||
Total | 244,030 | $ 246,200 | ||
Estimate of purchase price allocation | ||||
Cash and cash equivalents | 951 | |||
Accounts receivable | 823 | |||
Inventory | 1,539 | |||
Fixed assets | 226 | |||
Other assets | 5 | |||
Intangible assets | 110,100 | |||
Goodwill | 157,699 | |||
Total assets acquired | 271,343 | |||
Liabilities assumed: | ||||
Interest bearing debt | 16 | |||
Other current liabilities | 2,749 | |||
Deferred tax liabilities | 24,548 | |||
Total liabilities acquired | 27,313 | |||
Estimated fair value of net assets acquired | $ 244,030 |
BUSINESS COMBINATIONS - Identif
BUSINESS COMBINATIONS - Identifiable Intangible Assets Acquired (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Aug. 15, 2022 | Mar. 31, 2023 | |
Business Acquisition [Line Items] | ||
Fair Value | $ 4,485 | |
GeneSiC | ||
Business Acquisition [Line Items] | ||
Fair Value | $ 110,100 | |
Trade Names | ||
Business Acquisition [Line Items] | ||
Useful Life | 2 years | |
Trade Names | GeneSiC | ||
Business Acquisition [Line Items] | ||
Fair Value | $ 900 | |
Useful Life | 2 years | |
Developed Technology | GeneSiC | ||
Business Acquisition [Line Items] | ||
Fair Value | $ 49,100 | |
Useful Life | 4 years | |
Patents | GeneSiC | ||
Business Acquisition [Line Items] | ||
Fair Value | $ 33,900 | |
Useful Life | 15 years | |
Customer Relationships | ||
Business Acquisition [Line Items] | ||
Useful Life | 10 years | |
Customer Relationships | GeneSiC | ||
Business Acquisition [Line Items] | ||
Fair Value | $ 24,300 | |
Useful Life | 10 years | |
Non-Competition Agreements | ||
Business Acquisition [Line Items] | ||
Useful Life | 5 years | |
Non-Competition Agreements | GeneSiC | ||
Business Acquisition [Line Items] | ||
Fair Value | $ 1,900 | |
Useful Life | 5 years |
BUSINESS COMBINATIONS - Pro For
BUSINESS COMBINATIONS - Pro Forma Information (Details) - GeneSiC $ / shares in Units, $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) $ / shares | |
Business Acquisition [Line Items] | |
Revenue | $ | $ 11,476 |
Net income | $ | $ 79,741 |
Basic net income per share (in dollars per share) | $ / shares | $ 0.55 |
Diluted net income per share (in dollars per share) | $ / shares | $ 0.51 |
NONCONTROLLING INTEREST (Detail
NONCONTROLLING INTEREST (Details) $ in Thousands | 3 Months Ended | ||||
Feb. 13, 2023 USD ($) | Jan. 19, 2023 USD ($) | Aug. 19, 2022 USD ($) | Mar. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | |
Noncontrolling Interest [Line Items] | |||||
Fair Value | $ 4,485 | ||||
Goodwill | $ 161,442 | $ 161,527 | |||
Joint Venture Investment | |||||
Noncontrolling Interest [Line Items] | |||||
Purchase price of minority interest | $ 22,400 | ||||
Joint Venture Investment | Patents | |||||
Noncontrolling Interest [Line Items] | |||||
Fair Value | $ 1,000 | ||||
Amortization period | 5 years | ||||
Goodwill | $ 3,100 | ||||
Joint Venture Investment | Developed Technology | |||||
Noncontrolling Interest [Line Items] | |||||
Fair Value | $ 4,400 | ||||
Joint Venture Investment | Measurement Input, Discount Rate | |||||
Noncontrolling Interest [Line Items] | |||||
Joint venture, measurement input | 0.30 | ||||
Joint Venture Investment | Measurement Input, Royalty Rate | Developed Technology | |||||
Noncontrolling Interest [Line Items] | |||||
Joint venture, measurement input | 0.10 |